Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2015 Oct 16.
Published in final edited form as: Am Homeopath. 2008;14:56–74.

The Evolution of Homeopathic Theory-Driven Research and the Methodological Toolbox

Iris R Bell
PMCID: PMC4608383  NIHMSID: NIHMS132994  PMID: 26478917

“I’m like a man who’s been half-asleep all his life, trying to find out what he was like before he woke up.”

- Charlie in Daniel Keyes’ novel, Flowers for Algernon

Introduction

The purpose of this paper is to update the homeopathic community on the state-of-the-science in homeopathic research. Emerging data and new theoretical work are creating a quiet revolution in homeopathy of which clinicians in practice may not as yet know. These findings do not simply tilt at the windmill of trying to “prove” the validity of homeopathy to extreme skeptics (who will never be convinced), but, rather, provide a modern foundation for advancing the field overall and improving the clinical care available to patients. Extensive references are provided as resources for interested readers to use in rational discussions with not only other homeopaths, but also non-homeopathic colleagues currently unfamiliar with research progress in homeopathy. Skeptics and other people who are simply unaware of the research literature have the incorrect belief that there is “no” research evidence supporting the plausibility of homeopathy, biological effects of remedies, or the clinical effectiveness of homeopathic treatment. On the contrary, the evidence is published and accessible.

The progress falls into at least 4 specific areas: (1) introducing new strategies for designing randomized clinical trials that have greater external validity (faithfulness and relevance to actual homeopathic clinical practice); (2) developing a peer-reviewed, accessible literature of clinical observational studies on thousands of patients with acute and/or chronic conditions and adapting the tools of qualitative research methods; (3) synthesizing concepts from the cutting-edge science of complex nonlinear dynamical systems and network theory with homeopathic philosophy and practice theory to design theory-driven studies that advance understanding of the healing process; and (4) determining several different basic science laboratory methods for documenting the nature of homeopathic remedies to address the skeptics’ long-standing molecular implausibility argument against homeopathy.

In short, homeopathic research is moving forward—internationally—in exciting ways. At the same time, reasons for the political divide between allopathic and homeopathic perspectives on health care are becoming even more clarified in the research arena. Classical homeopathy holds not only a vitalistic rather than materialistic (allopathic) philosophy at its core, but the research methodology approaches most likely to help us understand homeopathy more deeply also fall into some allopathically less well-known and/or less well-accepted scientific approaches. Even though respected in scientific fields outside biomedicine, these methods are currently at the frontiers and sometimes fringes of biomedical research, such as qualitative methods and nonlinear dynamical complex systems and network science.

A key strategy for homeopathic researchers involves learning the language and current scientific interests of allopathic researchers in order to bridge the chasm between homeopathy and allopathy. As this paper will outline, the surprising results of a dialogue will include new ways of understanding and performing research on traditional homeopathic concepts such as health and disease (attractor patterns), miasms (epigenetics), center of gravity and suppression (networks), aggravations prior to improvements (dynamical destabilization, bifurcations, cusp catastrophes), Hering’s Law of Cure (self-organization), and even succussion in remedy preparation (epitaxy and turbulence with changes in pressure within liquids).

Modifications of Randomized Controlled Trial Designs in Homeopathy

When clinicians, insurance companies, and academics refer to “evidence-based practice,” they generally assume that the placebo-controlled, double-blind randomized controlled trial (RCT) is the gold standard for deciding whether or not a treatment “works.”1,2 The objective of an RCT design, which was introduced as a procedure for testing pharmaceutical drugs, is to determine if a given treatment prospectively (going forward in time) has specific biological effects above and beyond those that occur during treatment with a biologically inert placebo.

A placebo is a treatment indistinguishable from the verum intervention in terms of appearance, taste, smell, etc. but without the presumptive “active” ingredient to exert any direct biological effect. The assumption is that any changes are due to the psychology of the recipient (e.g., expectations, assignment of meaning), or, perhaps to the natural course of the disease.37 A recent study found that telling people that one placebo pill cost much more than another identical placebo pill led to higher ratings of painalleviating effects, apparently on the basis of perceptions of effectiveness based on cost alone.8 Notably, studies suggest that there are no universal placebo responders in the population and that the size of the placebo effect varies greatly from study to study.9,10 Some researchers have even debated whether or not placebos are particularly powerful.1115

RCTs give us answers on idealized mechanism-specific treatments in idealized patients, as most trials only study uncomplicated patients with a single intervention versus placebo for a short period of time (typically 2 to 4 months).1619 RCT results help guide public health and policy decisions about whether or not to recommend and spend money on a treatment for a population with a particular allopathic diagnosis. A major limitation of applying RCT results to individual cases, even for drugs, is that the results provide group averages for the verum treatment versus placebo patients. Consequently, a clinician gains only limited guidance from the results of any RCT as to how to tailor treatment for a specific individual patient in the full context of the patient’s unique presentation, other concomitant conditions, other drugs and treatments, treatment preferences, capacity for compliance, and economic circumstances.20,21 Applying statistical averages to the possible outcomes of a given individual in real-world practice is a risky endeavor. Even for pharmaceutical drugs, conventional medicine is moving toward individualized or personalized medicine through frontier research in systems biology, looking for genetic patterns to predict which people will be potentially helped or hurt by a specific drug.2224

Many RCTs of “homeopathy” test a single remedy or a combination remedy for all patients with a given allopathic diagnosis.25 This design flaw ignores the way classical homeopaths actually practice, that is, by individualizing remedy choice to the unique and total clinical pattern that each patient presents, irrespective of allopathic diagnosis.26 Moreover, most RCTs give the homeopath one chance to choose the remedy for the duration of the study. Many homeopaths would admit that it can take them multiple interviews and feedback on responses from a patient to determine the true simillimum, i.e., multiple tries. Presumably, less experienced homeopaths are more likely to have to try more remedies before finding the “correct” one, but even seasoned masters admit that it can take more than one attempt to find the right remedy. With combinations, there is no guarantee that any of the constituents or standardized potencies will be correct for the particular individuals who happen to enter the study.

Homeopathic researchers have arrived at two different possible solutions to the above problem. One way is to have two homeopaths with similar practice styles see the patient at the same time and require agreement on the single remedy choice with a high rating for their level of confidence.27,28 This method is better than having the fate of homeopathy stand or fall on the skills of a sole provider or only one remedy for all patients in a given research project, but is still susceptible to the risk that both homeopaths could miss the correct remedy the first time and the patient not respond.29 In fact, when Frei et al.3032 examined the clinical reality in children treated in an individualized homeopathy research study for attention deficit hyperactivity disorder (ADHD), they determined that it took their experienced homeopaths a median of 3 different remedies and a median of 5 months to find the treatment associated with a significant reduction in symptoms under real-world open (unblinded) screening conditions. They also recommended a research trial duration of 12 months, not 2–4 months, for homeopathy studies in ADHD.31

If a researcher designs a homeopathy study without taking this data into account, he/she runs the risk of diluting their “active” treatment group with people on individually inactive remedies, homeopathically speaking. Essentially, a varying proportion of the “active” group in a study, though receiving a real homeopathic remedy, will respond clinically to the remedy as if it were a placebo, that is, individually inert for them. The predictable result is that sometimes the “active” group will have average outcomes not significantly different from placebo group—and sometimes they will. Even if the homeopath identifies the correct remedy, a RCT study usually ends before clinicians expect to see maximal improvement in their patients. The brief duration of RCT designs for chronic conditions would miss true remedy-based therapeutic effects in many homeopathic patients, whose improvements begin to establish themselves later in the course of treatment.

Notably, once remedy response is established, homeopaths often report that their patients’ clinical improvements self-sustain for 1 to 10 years or more with infrequent and even no dose repetition and limited follow up visits with the homeopath. It may be particularly useful to compare the longitudinal course of patients who report improvements after verum individualized remedies versus those who receive complex homeopathy or placebo. The literature on the natural course of placebo effects suggests that they can peak early and dissipate within weeks or at least a few months after treatment begins.33

Furthermore, individualization may matter more for longer-term rather than short-term outcomes with CAM therapies. For example, one RCT study of Chinese herbal mixtures for patients with irritable bowel syndrome found that both individualized and standardized verum herbs produced greater improvements than placebo at the end of a 16-week RCT. However, once treatment stopped, only the patients who had received individualized herbs maintained their improvement 14 weeks later.34 Does individualized, classical homeopathy have a parallel advantage over placebo and/or isopathically-prescribed remedy with the passage of time? The literature has no studies on this question, to date.

Negative studies also are especially likely when the total patient sample size is small (as commonly happens in the world of limited funding for homeopathy studies), thereby leaving too few patients in the “active” group on homeopathically active remedies for them. This key point could help explain why the results of RCTs—and the meta-analyses based on collections of RCTs—sometimes are positive,25,3540 sometimes equivocal,41 and sometimes negative4244 in terms of homeopathic treatment showing different outcomes from those of placebo. In some studies, therefore, the negative result is true and valid. That is, the “active” group, diluted with people given inactive, hence placebo-like remedies for them individually, does not differ on average from the actual placebo group. However, the interpretation of such findings is muddled by the failure of the study design to test homeopathy as practiced—an empirical process of clinical care, involving iterative, adaptive and interactive decision-making over time.4547

An additional important methodological modification of RCTs that Frei et al. contributed is that they not only confirmed the ability of the remedy to reduce ADHD symptoms by half (in LM potencies), but that they showed the effects wore off in their LM responders after stopping the remedy for at least 4 weeks, early in treatment. The latter observation enabled a within-subject cross-over design. Then—and only then—did they put the pre-screened patients into a double-blind placebo-controlled randomized trial with a crossover design (each patient was assigned to active remedy followed by placebo or placebo followed by active remedy, with 6-week periods for each phase of the trial). Frei et al, using their modified RCT design, ended up with a positive study showing that “homeopathy works” significantly better than placebo in behavioral and cognitive functions,30 whereas a different, small and unscreened sample for a standard RCT study, designed without the homeopathically-relevant check for remedy activity, was negative.42

These points do not mean that homeopathy can or will “work” in every well-designed study for every patient, but they suggest methodological approaches for making rigorous study designs more ecologically valid, that is, appropriate for testing homeopathy scientifically, as actually practiced.48 Modified RCT methodologies, including studies termed pragmatic trials49,50 in which the homeopaths can adjust treatment as they would in real-world practice, should lead to more reproducible findings across clinical studies in homeopathy than is currently the situation. The data also suggest that homeopathy probably does not work equally well for everyone.51 Some acupuncture research offers a relevant precedent. Patients with recurrent cystitis who had received a particular Chinese medical diagnosis pattern did better than those with other initial Chinese diagnoses in a 4-week RCT format with 6-month follow-up.52 More research effort should address the triage question: that is, who can benefit most from homeopathy and thus should get such treatment versus who should receive early referral to a different form of therapy?

One hint in the research literature already is that people who are drawn to alternative systems (complementary and alternative medicine, CAM) such as homeopathy or acupuncture have higher scores on the personality trait of openness to experience.53 Personality traits usually have genetic, biological, and behavioral characteristics that can provide valuable clues for understanding how one person could respond better to homeopathy than another in the real world. For instance, the personality trait of absorption (the ability to immerse oneself in inner or outer experiences), which correlates with openness to experience, identifies fibromyalgia patients more likely to choose, when given a chance to switch groups under double-blind conditions, to remain in their randomly assigned group in which they began the study—not only for the verum group, but also even if the original group assignment turned out later to be placebo (and the placebo patients were not objectively better)!54,55 In any system of care, patients who adhere to recommended treatments over time have a better chance of experiencing favorable outcomes from an active treatment than those who stop treatment altogether or move on to the next doctor or treatment too quickly, before the initial treatment would have a chance to help.56

If it takes multiple remedies and several months to find the correct remedy for a patient, someone with a chronic disease who scores low for trait absorption may well have discontinued care too soon to benefit from homeopathic care. Some data support the latter hypothesis. A recent prospective observational study showed that Danish homeopathic patients with hypersensitivity illnesses who experience the best outcomes not only start with high expectations from treatment, but they also continue in maintenance treatment one year later.57

Another methodological strategy for modifying RCT design is to look for early objective biomarkers of responsivity to predict who will and who will not turn out to respond well clinically in the course of extended treatment. One promising approach is to use quantitative electroencephalography (qEEG). Conventional researchers from UCLA demonstrated that qEEG cordance, a computed ratio derived from relative and absolute power of an EEG frequency and correlated with neuroimaging techniques such as SPECT or PET brain scans, is measurably and uniquely different early in treatment for patients with major depression who turn out weeks later to be good antidepressant drug responders.5860 The drug responders exhibit a qEEG theta cordance pattern opposite to that of the eventual placebo responders. Both active and placebo responders differ from patients who fail to respond to active or placebo treatment.

Bell et al. adapted and extended the qEEG cordance method in their RCT of homeopathy in fibromyalgia patients, using olfactory administration of LM liquid remedy versus plain solvent in brief sniffs on laboratory test days.61 The patients on active remedy who had shown a significantly larger difference between qEEG alpha cordance during double-blind remedy sniffs versus those during plain solvent control sniffs exhibited the best clinical outcomes 3 months later, compared with non-responders to “active” remedies and patients on placebo. In other words, it may be possible on initial treatment to screen brain wave patterns identifying patients for whom the homeopath(s) have chosen a remedy that will turn out to be clinically effective. Once screened with qEEG, the potential responders would be the patients entered into the double-blind RCT. Potential non-responders from the screening phase would never enter the double-blind phase of the study and thus not weaken the statistical power of the study to find an effect of active homeopathic treatment versus placebo, if present.

Notably, in the fibromyalgia study, excellent responders were defined in a manner consistent with homeopathic practice,61 not merely in accord with allopathic standards for “good” outcomes. That is, it was not enough for a patient to have markedly less tender point pain on double-blind examination (a local effect); an excellent responder also had to score markedly better on their global rating for overall health (a global or patient-centered outcome). Some of the placebo patients had less pain and some placebo patients had better global health ratings, but no placebo patients at 3 months had both better global health and less tender point (local) pain. Such findings suggest the value of requiring drugs and placebos to meet homeopathic outcome standards—i.e., of producing patterns of improvements both in overall well-being/health and local symptoms, not just one or the other type of outcome, or even just in a list of multiple outcomes. Doing so will require allopathic drugs to compete in the person-wide homeopathic outcome arena, not merely their own, more narrow definition of one effect at a time.48

The current mainstream research political climate requires homeopathic remedies to perform as well as specific drugs in the allopathic drug arena, but ignores the usual nature of homeopathic clinical outcomes for judging efficacy of a treatment. It is time to turn the tables on allopathy. Homeopathic researchers must insist on fairer evaluation of allopathic and homeopathic medicines from not only an allopathic perspective, but also a homeopathic point of view. In other words, does a treatment produce patterns of good global and local outcomes (as expected from homeopathic remedies), not just good local outcomes one by one (as expected from allopathic drugs).

Allopaths dismiss “non-specific” effects as unrelated in a causal way to a given treatment.9 However, homeopaths predict that a single remedy can induce (cause) positive pattern outcomes in global well-being, energy, and multiple symptoms and dimensions of the person.62 Terminology can interfere with proper evaluation of clinical outcomes. Treatments typically have multiple effects, some desirable and others undesirable for the patient’s overall health and well-being. Favorable effects that allopaths label as “nonspecific” for drugs in their system of medicine, i.e., improvements in symptoms other than the chief complaint and enhancements in quality of life, are actually “specific” for homeopathy’s mode of action, i.e., predicted by the theory of the intervention.7 Also, good homeopathic results are not group averages computed item by item for each type of outcome. Notably, the widely-criticized63 Shang et al.64 meta-analysis of homeopathic RCTs published in Lancet found homeopathy no better than placebo. Shang et al. admit in their paper that they randomly chose only one outcome from each study for their analysis, even if multiple outcomes were reported. In contrast, good homeopathic outcomes clinically are profiles (pictures) of concomitant changes within the same individual. In the least, homeopathic researchers need to adapt a variety of analytic procedures already used by investigators in other fields65 where multivariate patient profiles rather than in single variables and longitudinal change processes are most important (e.g., profile analysis, reference 65, pp. 391–455).

Thus, the most appropriate statistical analyses require innovative approaches to assess patterns of initial presentation and then patterns of multiple responses within the same, rather than between different, subjects over time. For example, adapting techniques from what is called phylogenetic analysis 66,67 involving clusters of features of a given patient or the features of a series of initial and follow-up visits with an individual patient (e.g., word use patterns from transcripts and/or nonverbal behaviors from videotapes of each clinical visit) may be one way to begin to capture the baseline remedy picture and then the homeopathically good versus poor outcome pictures as they evolve.

At baseline, phylogenetic analytical tools could allow homeopathic researchers to test for and refine the clinical validity of remedy family and miasmatic characteristics as clusters of patient features at the beginning of treatment, as described in the diagnostic systems of Scholten68 or Sankaran69 and others. One study showed, for instance, that most of the plays attributed to Shakespeare sort together in particular regions for phylogenetic word use pattern, whereas most of the plays attributed to Marlowe sort into a different cluster of word use patterns. Only one of the plays attributed to Shakespeare falls into the word use pattern area where Marlowe’s plays cluster.67 Another analytic tool with a related purpose is grade-of-membership (GOM) analysis, which researchers have previously applied in analysis of remedy type categorization and provings data.7072 GOM looks for the degree to which an individual does or does not fall into membership in a particular category on the basis of a set of symptoms. In addition, a more mixed qualitative-quantitative approach to determining categorical domains from multiple open-ended descriptive items derived from expert opinions that card sort together is a method called concept mapping.73,74 In summary, there are several different, systematic research methodologies available to study what homeopaths do in clinical diagnosis—i.e., assemble, cluster, prioritize, and weight many pieces of biopsychosocial information about an individual as a picture in order to classify the person as a whole, using a single, specific, individualized category, a remedy type.

What questions could we ask of relevance to homeopathy? They would include: Do the word use patterns of people who need plant, animal, or mineral remedies75 cluster differently, e.g., using phylogenetic analysis or concept mapping of transcripts of case-taking interviews and moment-by-moment observer-coded observations of patient appearance and behaviors on videotapes? Do people with different miasmatic tendencies cluster empirically by their word use patterns into acute, psoric, sycotic, and syphilitic, let alone other proposed subtypes? We may be able to use and adapt available scientific methods to perform innovative studies and confirm, disconfirm, and/or refine proposed clinical constructs in homeopathic practice theory.

Allopathic genomics researchers are currently using phylogetic analysis methods to characterize different multi-gene activation patterns associated with particular phenotypes in the real world.66 Beyond phylogenetic analyses, however, allopathic researchers are even beginning to find evidence that genes set up risk for specific diseases, but require an interaction with the environment to be activated or inactivated in complex patterns—i.e., to manifest or not manifest a disease clinically. They have found, for instance, that cross-generational and early environment stressors such as lower socioeconomic status (SES) persistently modify the expression of genes involved in inflammation (epigenetics), thereby changing the level of risk for various subsequent allopathic diseases.7678 The latter research79 suggests that homeopaths who can explain the concept of miasms as acquired disease tendencies to scientists outside their field may now find epigenetics research collaborators open to accepting the concept of miasmatic influences on health and disease expression as plausible and testable. For allopaths, their unit of analysis is the emergent behavior of a person’s genes as modified by environmental interactions (phenotype); for homeopaths, their unit of analysis is the emergent behavior of the person as a whole, as modified by environmental interactions (specific remedy type). In fact, just as modern neuroimaging techniques helped acupuncture receive more serious scientific attention in recent years, contemporary genomics and epigenetics systems and multivariate-based research methods may be one route by which homeopathy can attract much greater scientific consideration.

Furthermore, effects that allopaths label as “side effects” (i.e., undesirable adverse effects in addition to any locally-desirable effects) of many allopathic drugs tend to occur less often with individually-chosen homeopathic remedies (where the single remedy is expected to cause multiple desirable improvements in multiple symptoms without adverse “side effects”—or adverse drug-drug interactions). In assessing both the positive and negative effects of a given treatment, the total picture of benefit versus risk should tilt in favor of homeopathic remedies and against allopathic drugs, as the results of several large-scale observational studies already suggest (see below). Again, pattern analysis should reveal the fuller picture for homeopathic outcomes better than methods that evaluate only one class of outcomes at a time.80

Clinical Research Tools Other than Randomized Controlled Trials

The Usefulness of Observational Trials for Studying Real-World Outcomes

In contrast with the mixed results of RCT studies of homeopathy, observational studies of all types reveal outcomes consistently favorable to homeopathy.8194 Types of observational study designs range from prospective longitudinal cohort to case-control to cross-sectional to case series. Researchers consider the case report, which is the most common way in which homeopaths report their clinical findings, to be the weakest observational design from a scientific perspective,1 even though it may help other clinicians better to understand their own individual patients.

Nonetheless, as an alternative research study design from both a practical and economic perspective, some allopathic medical researchers have begun to advocate for accepting the results of well-designed observational clinical studies as just as valid and reliable as RCT studies,95,96 without as much tendency to inflate bias as previously believed. The strongest design for observational studies usually involves a prospective, longitudinal evaluation of patient outcomes in which hundreds or thousands of consecutive patients are followed for many months to years.

What makes observational trials worthwhile? Even if a treatment works in an RCT, patients in the real world often fail to tolerate or even to use the treatment as prescribed for a host of possible reasons. Furthermore, long-term outcomes in real-world practice are often at odds with the findings from RCTs. As a result, the media regularly announce new warnings or outright withdrawals of FDA-approved drugs from the market, only after thousands or millions of patients have taken them, sometimes for years. Recent examples include increased cancer and cardiovascular risks from hormone replacement therapy, suicide risk from one anti-allergy drug, or increased heart attacks from certain anti-inflammatory drugs for arthritics, hypoglycemic medicines for diabetics, and antiviral drugs for HIV/AIDS. The reasons for the inability of RCTs to identify these tragic risks are complex, but likely include the use of fewer patients for shorter periods of time, enrollment of less sick patients and fewer drug-drug interactions (fewer concomitant non-study drugs are usually allowed in RCTs) in the RCT designs than occur in real world practice. As Tolle has commented, “Homeopathy and Chinese medicine are two examples of possible alternative approaches to disease that do not treat the illness as an enemy and therefore do not create new diseases.”97

Advantages of observational studies include the ability to follow larger numbers of patients for longer periods of time in the real-world context of everyday clinical care, although without randomizing or blinding the treatment given. The disadvantages of observational designs include their susceptibility to the risk of bias and expectation—e.g., patients self-select their providers and treatments. One group could end up with many younger or older people, sicker or less sick people, differential dropouts from treatment, people on varying types of additional conventional or CAM treatments in one group but not another. Any such factor could lead to incorrect conclusions about whether or not the treatment of interest in an observational study, as opposed to some other factor or an interaction of factors, was itself responsible for the outcomes.

Given those caveats, it is still striking that homeopathy performs extremely well in observational studies—large cross-sectional and prospective designs, as well as in the case series and case reports that most clinicians learn through texts, computer programs, clinical journals, and conferences. The large-sample observational studies of homeopathy in acute and chronic conditions report a 70–80% rate of clinical improvement and 80– 90% rates of patient satisfaction.8192

Preliminary systematic research on the role of the homeopath-patient relationship on outcomes suggests that greater perceived empathy by providers correlates with improvements in patients’ sense of empowerment. In turn, empowerment correlates with some, but not all, clinical gains made 3 months and 12 months after the start of homeopathic treatment.98 In short, the homeopath-patient relationship is important for good clinical outcomes, especially early in the treatment process, but not by any means the whole story. Also, observational studies of homeopathy demonstrate significant reductions in use of pharmaceutical drugs (and their associated costs), and better safety records than conventional drugs.99

What can practicing homeopaths do to participate in observational research? Practice-based networks of providers nationally and internationally can join with academic researchers to document results in everyday clinical practices, generating sample numbers in the hundreds to thousands, with follow-up possible for months to years, rather than only weeks (as in RCTs). Outcomes can include pattern changes in global and local symptoms rather than just in chief complaint, clinically-documented laboratory tests, medications usage, urgent care and emergency room visits and hospitalizations, complications, as well as mortality rates. Simple outcome questionnaires obtained periodically in cohorts of practice-based network patients, such as clinical global impression ratings, patient global health and individualized well-being ratings,100 and quality of life questionnaire scores, can also help document outcomes.88,89,101,102

Homeopaths often report taking 6–12 months to see marked improvement in chronically ill patients, and then finding sustained improvements for 10 or more years later, with only infrequent follow-up visits or repeat remedies. Only observational studies, not RCTs, will permit the extended follow-up periods during which homeopathy could show its potential advantages over allopathic treatment for reversing the downhill trajectory of chronic illness and lowering long-term health care costs over time.

The Relevance of Qualitative Research to Homeopathy

RCTs and observational studies usually involve quantitative analyses using numbers, measurement, counts, and statistical techniques to compare average outcomes of one group with those of another group. However, in many ways, individualized homeopathic clinical practice and homeopathic provings involve assessment approaches more similar to those used by some social science researchers such as anthropologists, sociologists, educators, and nurses, namely, qualitative methods. Qualitative methods focus on collecting and analyzing information by observing what people do and say.103

Qualitative data is derived from detailed, individual interviews and/or focus groups (e.g., 4–12 people, similar to the size of a prover group). Just as homeopathic case-taking depends heavily on the patient’s verbal capacity for describing details of symptoms, the raw data in qualitative research are verbatim transcripts of the participants’ own words from interviews, video, and/or audio recordings. Textbooks and computer programs (e.g. Ethnograph (www.qualisresearch.com), Atlas-ti (www.atlasti.com), NVivo (www.qsrinternational.com)) offer systematic ways to code and analyze qualitative data for patterns and themes. Applying formal qualitative research methods to homeopathic case interview and/or provings data could improve the ability of homeopaths and homeopathic researchers to describe their patients’ states and changes over time.104,105

The goals of quantitative and qualitative research are different. Quantitative research, using deductive reasoning, intends to explain an outcome causally in a presumably reproducible way over large numbers of people. Qualitative research, using inductive reasoning, intends to describe a process or phenomenon, with an emphasis on identifying patterns or themes. Some researchers combine quantitative and qualitative approaches in what they term mixed method studies. Published qualitative studies in homeopathy, acupuncture, and conventional medicine reveal exploratory insights not as easily found within the more rigid, confirmatory structure of most quantitative studies.106

For most homeopaths, qualitative research methods are far more relevant to what a clinician does in practice than are quantitative methods. In fact, clinicians could enhance their case analysis skills and the quality of their provings study data with additional formal, systematic training in qualitative research methods.103,107,108 Even though mainstream allopathic medical researchers place more value on quantitative rather than qualitative methods, qualitative approaches are more likely to characterize what homeopaths actually see, hear, and do in their practices. It makes practical sense to emphasize qualitative methods as highly relevant within the overall portfolio of qualitative and quantitative research efforts in homeopathy.

Future studies can also take advantage of the hundreds of already available videotaped cases recorded during intake and follow up sessions by practicing homeopaths worldwide. In the least, collaborations with qualitative researchers skilled in analyzing interview transcripts and videotaped patient behaviors could improve understanding of the evolution of change, even transformative change, in successful patients versus the stuckness of unsuccessful patients. Homeopathy needs many more qualitative research studies on what happens when patients respond well or poorly to treatment, in order to improve the quality of care for future patients and to design better quantitative studies.

Complexity and Network Science: Relevance to Homeopathic Research and Clinical Care

Homeopathy is a holistic clinical system of care. The emerging science of complex systems, nonlinear dynamics, and networks, which is inherently holistic in its fundamental worldview, provides a compatible framework for thinking about the nature of homeopathy,109116 disease, and healing. All living systems, including physiological subsystems such as the brain or the heart, are complex by nature. A complex system is an indivisible, interdependent network or set of interconnected and self-organizing parts whose emergent properties (behaviors) are greater than the sum of the properties of the parts.117,118 Any given complex system is actually embedded within some larger complex system, its environment, in a hierarchical but interdependent manner. In other words, the whole is greater than the sum of the parts. And, the whole and the parts intercommunicate.119

Life itself appears to depend on complex nonlinear dynamics, balanced between excess order and excess chaos.120122 Human flourishing may reflect optimal complexity (not too much order, and not too much chaos).123 Dynamical systems researchers have demonstrated that aging and many diseases typically lead to a loss of complexity in behavioral and physiological dynamics.124128 Some diseases involve an excess of disorder or chaos.129 Several homeopathic researchers have proposed that homeopathy is the therapeutics for healing disturbed dynamics in a person as a living system-network by optimizing complexity, balanced between order and chaos.115,116,130

In complexity, a living system’s dynamics manifest at the edge of chaos on one side and excessive order on the other. Systems tend to stabilize dynamically into certain repetitive (though not identical) behavioral patterns (attractors) that permit the system to interact and evolve within its environment.123,131,132 Complex and chaotic systems can end up in very different states depending on small differences in initial conditions.133 Similarly, in homeopathy, remedy responses depend on the state of the person at the moment of taking the remedy. Healthy people can get sick from taking a remedy, whereas sick people can heal from taking the same remedy.134 Yet, repeating a remedy that worked wondrously in the past for a seemingly similar condition may have very different clinical effects than it did the first time. Lack of reproducibility in homeopathy is often expected from a systems perspective, as the person taking the remedy has evolved over time—and is never again in exactly the same dynamical place from hour to hour, month to month, year to year. The effects of allopathic drugs are generally more reproducible than are those of homeopathic remedies. However, treatment goals within the two systems of care are very different. Allopathic drugs block fixed end organ disturbances by using brute force with continuous drug levels, whereas homeopathic remedies treat disturbed system dynamics by timed episodic introduction of a small, salient treatment stimulus into the living system, i.e., the remedy (see below).109,134

Complex systems tend to organize structurally and dynamically in self-similar ways at every level of organizational scale (e.g., scale can be at a level of resolution of molecules, cells, organs, organ systems, person, social groups, human society, the ecosphere, or even the universe itself).118,135 In like manner, homeopaths search for dynamical themes that pervade the organism’s behaviors at the general, mental, and specific physical symptom behavioral levels in order to identify the correct simillimum. The behavioral pattern of the person is itself a self-similar microcosm of the behavioral pattern of the simillimum remedy in nature as part of the ecosystem from which it comes. The microcosm-macrocosm viewpoint overlaps those of other holistic systems of CAM such as traditional Chinese medicine or Ayurveda.

That is, the homeopath performs case analysis looking for self-similar dynamical patterns across every level of the person. The global level of scale involves characteristic ways in which an individual generally experiences symptoms, whether they manifest in mental, emotional, or physical planes.47 A patient’s generalities need to match the general symptom picture of the specific remedy (e.g., better with cold environmental temperatures, worse in a crowd, ameliorated from drinking milk, worse at 10 am daily, recurring every autumn, etc.). The next most important emphasis in the hierarchy of homeopathic practice is mental symptoms, e.g., delusion of being alone in the wilderness, sadness hearing music, all complaints aggravated by talking. Mentals represent the deepest level of a living being. Manifest mental disturbances profoundly change the way a person lives his/her life.

In nonlinear dynamics, the set of behavioral patterns toward which the system gravitates are called attractors. Unhealthy attractors (fixed point or limit cycle) tend to be tightly repetitive and inflexible or rigid—with a very limited repertoire of responses to environmental challenges (biological, physical, chemical, or social in nature).131,132,136142 When in transition between attractors (cf., a homeopathic aggravation), the system temporar-and inflexible or rigid—with a very limited repertoire of responses to environmental challenges (biological, physical, chemical, or social in nature).131,132,136142 When in transition between attractors (cf., a homeopathic aggravation), the system temporarily destabilizes and can sometimes shift abruptly (bifurcate) into unstable dynamics involving opposite states before settling into a new, more stable attractor, or go on to develop even more unstable (unpredictable) chaotic dynamics (Figure 1). Healthy attractors tend to have more flexibility, adaptability, and resilience in the states through which the system can move when perturbed by influences or changes in the environment.123,143

Figure 1.

Figure 1

The logistic map is a simple quadratic function with the special property of describing the change in a system from a fixed point attractor [corresponding to a rigid, stuck, unhealthy dynamical process], to a periodic attractor, to chaos as a bifurcation variable increases in value. It originated in studies of population dynamics. [Excessively frequent remedy repetition may cause incurability by pushing the system dynamics to bifurcate excessively and end in chaos]. (Sources: Image from Kaplan D and Glass L. Understanding Nonlinear Dynamics, Springer-Verlag, 1995, p. 31; explanation from www.societyforchaostheory.org/tutorials/#1, accessed 4/27/08)

Sherr aptly describes the homeopathic clinical diagnostic process as a search for stuckness in a person’s behavior, i.e., the verb of the case, “repeating on every level” (i.e., a self-similar rigid attractor pattern).144 Sherr goes further to describe allopathic pathological labels as a set of static nouns of little use for homeopathic diagnosis (the ultimate in fixed order or lost complexity in a system’s dynamics). In systems science terms, generals are the person-system’s emergent global patterns and mentals are the behavioral attractor patterns at the next highest level of organization in the network of the person, that is, the local brain with its own emergent behaviors (e.g., conscious awareness, sensations, delusions, dreams). Homeopathic stuckness translates into a rigid dynamical attractor pattern; health into an optimally complex attractor pattern (see Figure 2).

Figure 2.

Figure 2

State space grid method examples of a relatively flexible mother-child interaction (left)[healthier dynamics] and a relatively rigid one (right)[unhealthy, repetitive/stuck dynamics], coded by research observers from videotaped behaviors. Mother behavior is plotted on the x-axis and child behavior on the y-axis. Two different behaviors exhibited in real-time by a single individual can also be plotted with this method (Source: Hollenstein 2007, reference 140, used with permission).

Thus, it is possible to understand a homeopathic aggravation as an abrupt (discontinuous) remedy-induced bifurcation in the attractor dynamics of the individual (a cusp catastrophe, in systems terms), one that may resolve into a healthier (optimally complex) or unhealthier (overly ordered or overly chaotic) pattern with time. After any aggravation period, patients commonly describe themselves as passing through a “foggy” period but experiencing their usual symptoms (e.g., asthma attacks), but with less frequency and less severity—a pattern predicted for a system in a phase transitional pattern of change in its dynamics. Clinically, at the social level, the healthier person’s behavioral dynamics can eventually manifest as an abused wife effectively confronting and overcoming the series of difficulties involved in leaving the spouse, or as a grown, but dependent child getting a job, moving out on his own, and managing to set up an independent life from his parents without moving back home again.

In his classic homeopathy text,47 Vithoulkas describes the importance of watching the behavioral response of the patient to a remedy dose and waiting for a recognizable symptom pattern to emerge and stabilize before repeating or changing the remedy. He observes that repeating a remedy too often can engraft a disease pattern and giving too many different remedies can make a case incurable. From a complex systems perspective, pushing a dynamical system into repeated bifurcations before it can restabilize can in fact generate chaotic dynamics, an excessively disorderly state of function beyond the healthy state of optimal complexity (Figure 1).

Health in Vithoulkas’ terms of freedom at every level of being47 means that a person will react to, but nonetheless bounce back from, environmental changes/challenges (health involves resilience in the face of negativity, not a rigidly Pollyanna-like positivity). A healthy person can adapt to his/her environment without becoming stuck in a dysfunctional behavior pattern of rigidity (loss of complexity with excessive order as in a fixed point attractor pattern or a limit cycle attractor) or overwhelming disorganization (loss of complexity in the other direction, as in an extremely chaotic attractor pattern).123

Among health care systems, homeopathy appears to be unique in its actions. Homeopathy seems to destabilize a living system out of a rigid or chaotic attractor pattern of disease while providing a template for the whole person’s dynamics to shift and restabilize across global and local levels of organization into a more adaptive complex behavioral attractor pattern. Removing obstacles to cure in this scenario by improving diet, adding beneficial lifestyle habits such as exercise and meditation, avoiding chemical and social toxins, and adding social support all translate in systems terms into relocating the organism into a less challenging environmental fitness landscape in which he/she can better recover.135 Early the course of treatment, the system dynamics will be more wobbly and vulnerable to reverting to old attractor patterns when exposed to environmental stressors. However, once the healthy dynamical pattern is established and stabilized with the passage of time, the dynamical system should be able to throw off adverse effects of subsequent encounters with environmental stressors.

In this way, homeopathic therapy focuses on temporality in terms of timing of the treatment stimulus (remedy dosing) and shifting dynamics of the system. In contrast, allopathic medicine largely ignores dynamics and focuses its treatment more on spatiality in terms of fixed structural lesions in end organs. Rarely, allopathic researchers in dynamical systems have tried to create new therapies by timing their interventions at different points in the system dynamics to interrupt, for instance, the abnormal electrical patterns of epilepsy or apnea.129,145 Homeopaths apparently already have an empirical way to do so on an individualized basis for the system as an indivisible whole.

Homeopathic researchers should be able to document unhealthy, transitional, and healthy dynamics of individual patients by measuring the behavioral and physiological patterns during repeated assessments over time. These ideas further suggest that the best way to look for the effects of homeopathic remedies is to follow patients with repeated measurements over various time scales, both short-term and long-term, after the first administration of the simillimum.19 Such a conceptualization translates into the importance of studying the healing process to the point of cure (the pattern and trajectory of patients over time) to capture what homeopathy claims to do for patients.

For example, what are the system dynamical effects over time of treatment with simillimum as compared with incorrect homeopathic remedy, allopathic drug, placebo, and the natural course of the disease? Do the system dynamics revert toward an unhealthy attractor pattern when a patient antidotes or goes too long between doses of a high potency remedy? Is there a value to giving daily LM or low potency doses in water to perform small course corrections regularly in the shift toward healthier dynamics? Dynamical studies of individual patient behavioral patterns at the global (person) level of organization (e.g., mentals and generals—moods and interpersonal behaviors) and at a more local (physiological hub, heart) level (e.g., complexity of heart rate variability) during the homeopathic treatment process can begin to give clinicians richer behavioral information than just summaries of symptoms gleaned from follow up patient interviews.

In the sensation method, Sankaran’s approach of watching for nonverbal behaviors (gestures) of the patient during visits may offer guidance as to which individual behavioral dynamics are most important to assess in clinical research.69,75 Observing dynamical shifts during treatment may reveal if the homeopath has chosen the correct remedy and if it is still acting. Monitoring behavioral and physiological dynamics simultaneously146 may also show early relapses in order to time a remedy re-dose and keep the person’s system moving within a healthier attractor pattern of multidimensional behaviors toward cure.109

Complex dynamical systems researchers are able now to graph the temporal patterns of behaviors from videotapes and of physiology from continuous recordings of individual patients or social groups—and show differences between healthy and unhealthy dynamics.131,143,146,147 The techniques of dynamical systems science are readily adaptable for analyzing the videotaped behaviors of patients in homeopathic interviews, their reactions to experimental stressors, and/or their physiological changes during successful and unsuccessful treatment. With interdisciplinary studies, homeopathic researchers may be able to learn more about how an effective remedy triggers constructive change and how an ineffective remedy triggers no change, limited change, or even destructive change in a patient.148

For example, developmental psychology researchers use brief videotaped sessions to evaluate the effects of successful and unsuccessful multimodal community-based therapy for children with severe conduct disorders. These investigators have demonstrated that the initially rigid parent-child dynamics either destabilize and change toward more flexible, healthier patterns leading to good outcomes, or stay inflexible and end with poor outcomes (Figure 3).143,146 Using these same methods to study the process of change during homeopathic treatment in children with conduct and other behavioral disorders is an obvious next step for homeopathic researchers. Other investigators have measured differential behavioral complexity in daily mood fluctuations of persons with affective disorders149,150 or in the computerized task performance of adults with other chronic psychiatric conditions such as obsessive-compulsive disorder or borderline personality disorders.142 Creative tasks themselves transiently increase complexity of EEG dynamics,151 whereas paternal history of alcoholism79 or personal history of probable Alzheimer’s disease lower EEG complexity.152 Physiology researchers have shown that it is possible to differentiate patients with congestive heart failure from those with atrial fibrillation from healthy normals using complex dynamical systems analyses of heart rate variability patterns.127,128,153 Utilizing these and other dynamical assessments to evaluate behaviors of the individual person and his/her physiology could provide valuable tools to study homeopathic treatment in persons with a broad range of clinical conditions, not just developmental, psychiatric, or cardiological disorders.

Figure 3.

Figure 3

Schematic diagram of the relationship between real-time variability and a phase transition in developmental time [compare the possible evolutionary system dynamics of a chronic disease state at the time of remedy administration (far left), through possible aggravation, destabilization and dynamical self re-organization during a phase transitional treatment period [middle two grid portraits] and restabilization into different, dynamics after treatment [far right]. The new attractor pattern will be different from the original attractor, perhaps healthier (more flexible) or less healthy (more rigid), depending on the success of the treatment (Source: Hollenstein 2007, reference 140, used with permission)

Group data from a study of isopathic prescribing support the potential value of embarking on dynamical systems research in homeopathy. Hyland and Lewith observed evidence of the temporal effects of a clinically ineffective, but partially active homeopathic remedy (dust mite 30c) in adult asthmatics.115,154 Although the allopathic outcome values for verum and placebo did not differ at the 16 week endpoint of a conventional RCT study, the temporal patterns of change after the remedy versus placebo administration were markedly different. The remedy triggered oscillatory, sinusoidal dynamics over time in each of the outcome measures (global asthma activity, lung function performance, and self-rated mood), whereas the placebo led to much flatter, less variable values over time. The researchers concluded that even incorrect homeopathic remedies can act as stimuli to destabilize hub behaviors within the dynamics of the complex living system. Isopathic dust mite was apparently biologically active, but not clinically therapeutic in the above study. Thus, the conclusion that homeopathically-prepared remedies are “just placebos” is incorrect, as they are not necessarily biologically inert even when prescribed in a non-classical manner with a non-therapeutic result.

Global and local aspects of a complex network system are mutually interactive and influential.155 Similarly, a remedy has the overall potential to trigger a wide range of global and local specific changes in an individual, but it is very difficult to predict precisely which changes will occur when and with what intensity or duration. Nonetheless, in a complex network, the system has more influential hubs (highly connected and impactful points) and less influential nodes.156 Hering’s Law of Cure maps well onto the notion that a human being, as a nonlinear dynamical hierarchically self-organizing complex system, will change in response to a remedy stimulus in accord with how globally and locally a treatment can act (from above downward, from inside outward, in reverse order of time of original symptom appearance).

As classical homeopaths have observed, it is essential to choose a remedy that matches the deepest and most pervasive disturbance throughout the person to mobilize the most extensive change and healing. If a clinician ignores the generals and mentals and aims treatment at too low an organizational level of the person (e.g., a specific physical symptom), then the shift in disease dynamics could move anywhere else within the system to other hubs and nodes connected to the treated local node, including into more important organs (suppression). Complex network theory is consistent with this model.119,155,156

The ideal remedy addresses the patient’s physicals as well as the generals and mentals precisely because of the self-similar expression of the disturbance across all levels of the human being. Thus, a suppressive treatment might improve complexity of local target organ dynamics (e.g., relieve skin symptoms) at the cost of triggering lost complexity and excessively rigid dynamical order at higher levels of system organization (e.g., initiate depressed mood). The true advantage of classical homeopathy is its ability to disrupt disease dynamics and redirect the self-similar global and local system dynamics simultaneously to reorganize across all levels of network organization toward healthier patterns (see summary concepts—Table 1).

Table 1.

Summary of overlaps between homeopathic and dynamical systems concepts

Homeopathic Concept Dynamical Systems Research
Concept
Disease states/remedies and health express themselves through unique patterns of symptoms (behaviors) Attractor patterns—rigid (stuck), flexible (resilient)
Small doses produce big effects Nonlinearity
Timing of intermittent dosing when remedy picture stabilizes (or begins to reverse toward disease state) Sensitive dependence of system response on initial conditions
Aggravations and reversals in direction of illness trajectory Phase transitions, bifurcations, and cusp catastrophe events
Removing obstacles to cure Fitness landscape within the environment
Hering’s Law of Cure Self-organization

Emerging Research in Basic and Preclinical Science

The elephant in the room for homeopathy has long been the implausibility argument, i.e., that the remedies diluted beyond Avogadro’s number (e.g., 12c and above) have no remaining source molecules and thus cannot exert specific biological activity.157,158 This flawed molecular argument derives from incorrect assumptions that high school chemistry is the only science relevant to homeopathy. Although molecular composition is one way to describe an agent, it is not the only one. The key to homeopathic remedies may lie not in their molecular composition, but rather, in the dynamical network structure of the solvent molecules in which they are prepared.159162

Remedies begin with material source substances. However, remedies are not only diluted in solvents, typically ethanol-water mixtures; they are succussed. Succussion generates tremendous amounts of turbulence and pressure changes in the liquid solvent. Pressure changes can produce nanobubbles and persistently modify the organizational network structure of a liquid phase solvent even at room temperature.159,160,163 In solid phase, pressure changes can produce very different materials; for example, soft graphite and hard diamond are both different structural organizations of the same molecular composition, i.e., carbon, generated by differences in pressure. Succussion can also produce dispersed colloids or sols (which are not solutions); and marked changes in pH can disrupt colloids (see below). Papers by Roy et al.,159,160,163 Chaplin,162 Elia et al,164166 and Rey167,168 detail rigorous scientific arguments and empirical data that refute the molecular composition hypothesis offered by skeptics of homeopathy.

The experimental evidence supports a different hypothesis—that is, that the solvent for homeopathically-prepared remedies involving both dilution and succussion has unique physicochemical properties. The techniques that are demonstrating unique homeopathic remedy properties include calorimetry,169 thermoluminescence,167,170 Raman spectroscopy, and UV-vis spectroscopy,160 but not NMR171 or infrared spectroscopy.160 The data indicate that remedy preparation produces an increase in the organized order of the solvent molecules, as distinguishable from unsuccussed dilutions and remedy source-free succussed solvent controls. Treating a remedy with an extreme change in pH or x-ray leads to release of greater amounts of energy from the remedy liquid than from controls. The energy release reflects disruption of order in the structured water and ethanol solvent molecules. Some researchers propose that the order derives from dynamically-shifting hydrogen bonds between water molecules,167,168 and others suggest that weaker van der Waals forces159 may be in play. It also appears that silicate contaminants from the walls of glass containers may help stabilize homeopathically-prepared remedies in liquid phase, but do not, in and of themselves, account for the unique properties of one remedy compared with another.172

Much more basic science research is needed, but researchers are finally on their way to unraveling the nature of homeopathic remedies. The convergence of findings from several different laboratories around the world using several different types of technology makes the validity of the conclusions more believable than when only one research group claims findings with only one technology.

The calorimetry research group has reported a particularly striking observation that needs replication using the same and other technologies in independent laboratories. That is, Elia et al.166,173 find that the amount of heat released in calorimetric measurements when they disrupt the pH of a homeopathic remedy with a strong alkali in a test tube increases with the passage of time. Most molecular-based drugs lose their potency sitting on the shelf, but Elia’s group reports that re-testing a remedy left on the shelf for months often strengthens the findings. If verified, remedies appear to be seeding their own formation in the solvent at rest, at room temperature, that is, evolving over time. This observation could have implications for how a remedy acts in a living system.

Do remedies seed water “cluster” formation throughout the body water and thereby broadly affect function? Water is a hub molecule in most biochemical networks.156 Water also plays an essential role in the structural configuration of proteins in the cells of living systems.174177 Some investigators have proposed that water clusters are necessary for keeping the cell’s proteins properly folded (organized) for their functional roles.175 This is one of several possible models for how a remedy could act,178181 though other work by del Giudice et al.182185 suggests a role for electrodynamical effects of homeopathically-prepared remedies in water solvent. Still other investigators have invoked macro-entanglement and other quantum mechanical phenomena in the ability of remedies to induce the dramatic and extensive changes in health that homeopathic patients can report.130,186188

Clearly, researchers have more work ahead,189 but it is likely that the processes that homeopathic remedies invoke to induce shifts in living system function are different from allopathic molecular pharmaceutical lock-and-key drug-receptor interactions. Other research evidence in the literature demonstrating effects of homeopathically-prepared remedies on biological systems in test tubes (in vitro)190194 and in animals (in vivo)195206 provide a limited, but important, foundation for the evolution of understanding of when and how remedies work. One practical result of the basic science work could be to improve quality standards for homeopathic remedy manufacturers who currently can only test for unwanted contaminants with conventional tools, but not for the remedy activity itself. Other research studies can help resolve clinical debates, such as what factors do and do not antidote remedy effects.206

Conclusions

The current value for doing homeopathic research encompasses at least three major areas: (1) to optimize clinical management and care of patients; (2) to expand our understanding of nature and healing; (3) to use better-designed studies with good external and internal validity for testing homeopathy in patients with various conditions and identify who should and who should not use homeopathy. In conventional medicine (allopathy), clinicians and researchers have a division of labor of sorts. Most medical doctors have little formal training in research methods and do not want to perform scientific studies themselves. Other MDs and many PhDs choose career paths focused on research in academia and in industry. Nonetheless, allopathic medical schools expect the clinicians they graduate to be informed professional consumers and critics of the published research literature.

As part of the maturation of contemporary professional homeopathy worldwide, it is time for the educational organizations in the field to focus not only on developing good clinical providers, but also clinicians who can intelligently understand and critique the relevant research literature beyond case reports and provings. Again, this does not mean that homeopathic clinicians must become independent researchers. Homeopaths simply need to know how to argue the case for and against their own field scientifically and to think about the implications of new findings for their clinical practice, in an up-to-date and rigorous manner. Beyond becoming informed professionals, some homeopaths also may want to form or join practice-based research networks in collaboration with academic researchers.

The field also needs concerted efforts to develop and cultivate a critical mass of dedicated researchers, institutions where they can work (both academic and private foundations), and funding sources to support more studies advancing homeopathy. One of the many lessons of the Flexner report in the U.S. for homeopathy in retrospect should be that science, beliefs based on world views, politics, and economics are intertwined in human society. Science in the real world is not an idealized ivory tower of pure inquiry,207 and skeptics are often using the results of scientifically-flawed studies to attack homeopathy on what they consider to be “scientific” grounds.158 Homeopaths must be prepared to critique positive and negative studies on the basis of methodology rather than ideology and to debate the implications of a given set of findings in context of the rest of the research literature.

If homeopathy constitutes a threat to the beliefs and/or economic interests of the politically dominant allopathic system of care and the pharmaceutical industry with which it is tied, it is naïve to expect allopathic research institutions to support or encourage homeopathic science.208 For the survival and growth of the field, it is time for homeopaths and their supporters to face the latter reality and take action accordingly. The potential for enormous progress in understanding what homeopathy has to teach us about health, disease, healing, and the nature of reality is palpable.209 Science is one path for making such progress—and now, it offers homeopathy an array of new methodological tools that allopathic medicine has largely overlooked as unnecessary to study pharmaceutical drugs. Homeopathic remedies are something remarkable (perhaps with strange and peculiar, but not necessarily rare properties), and they are not pharmaceutical drugs. This is our challenge and our opportunity.

Biography

Dr. Iris Bell is Professor of Family and Community Medicine, Psychiatry, Psychology, Medicine (Program in Integrative Medicine), and Public Health at the University of Arizona in Tucson, Arizona. She is licensed in homeopathy and allopathic medicine in Arizona. An interdisciplinary researcher, she has published over 100 scientific papers and two dozen book chapters on her work. Her recent homeopathic studies have been funded by the National Institutes of Health, including career grant K24 AT000057. She also consults for Standard Homeopathic/Hyland’s Inc. Her forthcoming book for consumers is Getting Whole, Getting Well: Healing Holistically from Chronic Illness (Morgan James Publishing, 2008), www.holisticmedicinetips.com

ibell@u.arizona.edu

Bibliography

  • 1.Jonas WB. The evidence house: how to build an inclusive base for complementary medicine. Western Journal of Medicine. 2001;175:79–80. doi: 10.1136/ewjm.175.2.79. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Jonas WB. Building an evidence house: challenges and solutions to research in complementary and alternative medicine. Forsch Komplementarmed Klass Naturheilkd. 2005;12:159–167. doi: 10.1159/000085412. [DOI] [PubMed] [Google Scholar]
  • 3.Moerman DE, Jonas WB. Deconstructing the placebo effect and finding the meaning response. Annals of Internal Medicine. 2002;136:471–476. doi: 10.7326/0003-4819-136-6-200203190-00011. [DOI] [PubMed] [Google Scholar]
  • 4.Caspi O, Bootzin RR. Evaluating how placebos produce change. Logical and causal traps and understanding cognitive explanatory mechanisms. Evaluation & the Health Professions. 2002;25:436–464. doi: 10.1177/0163278702238056. [DOI] [PubMed] [Google Scholar]
  • 5.Kirsch I, Scoboria A. Apples, oranges, and placebos: heterogeneity in a meta-analysis of placebo effects. Advances in Mind-Body Medicine. 2001;17:307–309. discussion 312–8. [PubMed] [Google Scholar]
  • 6.Stewart-Williams S, Podd J. The placebo effect: dissolving the expectancy versus conditioning debate.[see comment]. [Review] [121 refs] Psychological Bulletin. 2004;130:324–340. doi: 10.1037/0033-2909.130.2.324. [DOI] [PubMed] [Google Scholar]
  • 7.Bootzin RR, Bailey ET. Understanding placebo, nocebo, and iatro-genic treatment effects. J Clin Psychology. 2005;61:871–880. doi: 10.1002/jclp.20131. [DOI] [PubMed] [Google Scholar]
  • 8.Waber RL, Shiv B, Carmon Z, Ariely D. Commerical features of placebo and therapeutic efficacy. JAMA. 2008;299:1016–1017. doi: 10.1001/jama.299.9.1016. [DOI] [PubMed] [Google Scholar]
  • 9.Walach H. The efficacy paradox in randomized controlled trials of CAM and elsewhere: beware of the placebo trap. Journal of Alternative & Complementary Medicine. 2001;7:213–228. doi: 10.1089/107555301300328070. [DOI] [PubMed] [Google Scholar]
  • 10.Walach H, Jonas WB, Ives J, Van Wijk R, Weingartner O. Research on Homeopathy: State of the Art. Journal of Alternative and Complementary Medicine. 2005;11:813–829. doi: 10.1089/acm.2005.11.813. [DOI] [PubMed] [Google Scholar]
  • 11.Kirsch I, Moore TJ, Scoboria A, Nicholls SS. The Emperor’s New Drugs: An Analysis of Antidepressant Medication Data Submitted to the U.S. Food and Drug Administration. Prevention & Treatment. 2002:5. journals.apa.org/prevention/volume5/pre0050023a.html. [Google Scholar]
  • 12.Wampold BE, Minami T, Tierney SC, Baskin TW, Bhati KS. The placebo is powerful: Estimating placebo effects in medicine and psychotherapy from randomized clinical trials. J Clin Psychology. 2005;61:835–854. doi: 10.1002/jclp.20129. [DOI] [PubMed] [Google Scholar]
  • 13.Lambert MJ. Early response in psychotherapy: further evidence for the importance of common factors rather than ‘placebo effects.’. J Clin Psychology. 2005;61:855–869. doi: 10.1002/jclp.20130. [DOI] [PubMed] [Google Scholar]
  • 14.Borkovec TD, Sibrava NJ. Problems with the use of placebo conditions in psychotherapy research, suggested alternatives, and some strategies for the pursuit of the placebo phenomenon. J Clin Psychology. 2005;61:805–818. doi: 10.1002/jclp.20127. [DOI] [PubMed] [Google Scholar]
  • 15.Hrobjartsson A, Gotzsche PC. Is the placebo powerless? Update of a systematic review with 52 new randomized trials comparing placebo with no treatment. [Review] [59 refs] Journal of Internal Medicine. 2004;256:91–100. doi: 10.1111/j.1365-2796.2004.01355.x. [DOI] [PubMed] [Google Scholar]
  • 16.Verhoef M, Lewith G, Ritenbaugh C, Thomas K, Boon H, Fonnebo V. Whole systems research: moving forward. Focus on Alternative and Complementary Therapies. 2004;9:87–90. [Google Scholar]
  • 17.Hyland ME. Methodology for the scientific evaluation of complementary and alternative medicine. Complement Ther Med. 2003;11:146–153. doi: 10.1016/s0965-2299(03)00070-0. [DOI] [PubMed] [Google Scholar]
  • 18.Aickin M. Beyond randomization. Journal of Alternative & Complementary Medicine. 2002;8:765–772. doi: 10.1089/10755530260511775. [DOI] [PubMed] [Google Scholar]
  • 19.Aickin M. The importance of early phase research. J Altern Complement Med. 2007;13:447–450. doi: 10.1089/acm.2007.6370. [DOI] [PubMed] [Google Scholar]
  • 20.Fønnebø V, Grimsgaard S, Walach H, Ritenbaugh C, Norheim AJ, MacPherson H, Lewith G, Launsø L, Koithan M, Falkenberg T, Boon H, Aickin M. Researching complementary and alternative treatments—the gatekeepers are not at home. BMC Med Res Methodol. 2007;7:7. doi: 10.1186/1471-2288-7-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Freeman AC, Sweeney K. Why general practitioners do not implement evidence: qualitative study. Bmj. 2001;323:1100–1102. doi: 10.1136/bmj.323.7321.1100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Ahn AC, Tewari M, Poon CS, Phillips RS. The limits of reductionism in medicine: could systems biology offer an alternative? PLos Medicine. 2006;3:e208. doi: 10.1371/journal.pmed.0030208. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Mesarovic MD, Sreenath SN, Keene JD. Search for organising principles: understanding in systems biology. Syst Biol (Stevenage) 2004;1:19–27. doi: 10.1049/sb:20045010. [DOI] [PubMed] [Google Scholar]
  • 24.Hood L, Heath JR, Phelps ME, Lin B. Systems biology and new technologies enable predictive and preventative medicine. Science. 2004;306:640–643. doi: 10.1126/science.1104635. [DOI] [PubMed] [Google Scholar]
  • 25.Oberbaum M, Yaniv I, Ben-Gal Y, Stein J, Ben-Zvi N, Freedman LS, Branski D. A randomized, controlled clinical trial of the homeopathic medication TRAUMEEL in the treatment of chemotherapy-induced stomatitis in children undergoing stem cell transplantation. Cancer. 2001;92:684–690. doi: 10.1002/1097-0142(20010801)92:3<684::aid-cncr1371>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  • 26.Kron M, English JM, Gaus W. Guidelines on methodology of clinical research in homeopathy. In: Ernst E, Hahn EG, editors. Homeopathy: a critical appraisal. Oxford: Butterworth-Heinemann; 1998. pp. 9–47. [Google Scholar]
  • 27.Bell IR, Lewis DA, 2nd, Brooks AJ, Schwartz GE, Lewis SE, Walsh BT, Baldwin CM. Improved clinical status in fibromyalgia patients treated with individualized homeopathic remedies versus placebo. Rheumatology. 2004;43:577–582. doi: 10.1093/rheumatology/keh111. [DOI] [PubMed] [Google Scholar]
  • 28.Chapman EH, Weintraub RJ, Milburn MA, Pirozzi TO, Woo E. Homeopathic treatment of mild traumatic brain injury: A randomized, double-blind, placebo-controlled clinical trial. Journal of Head Trauma Rehabilitation. 1999;14:521–542. doi: 10.1097/00001199-199912000-00002. [DOI] [PubMed] [Google Scholar]
  • 29.Dean ME, Coulter MK, Fisher P, Jobst K, Walach H. Reporting data on homeopathic treatments (RedHot): a supplement to CONSORT. Homeopathy. 2007;96:42–45. doi: 10.1016/j.homp.2006.11.006. [DOI] [PubMed] [Google Scholar]
  • 30.Frei H, Everts R, von Ammon K, Kaufmann F, Walther D, Hsu-Schmitz SF, Collenberg M, Fuhrer K, Hassink R, Steinlin M, Thurneysen A. Homeopathic treatment of children with attention deficit hyperactivity disorder: a randomised, double blind, placebo controlled crossover trial. Eur J Pediatr. 2005;164:758–767. doi: 10.1007/s00431-005-1735-7. [DOI] [PubMed] [Google Scholar]
  • 31.Frei H, Everts R, von Ammon K, Kaufmann F, Walther D, Schmitz SF, Collenberg M, Steinlin M, Lim C, Thurneysen A. Randomised controlled trials of homeopathy in hyperactive children: treatment procedure leads to an unconventional study design Experience with open-label homeopathic treatment preceding the Swiss ADHD placebo controlled, randomised, double-blind, cross-over trial. Homeopathy. 2007;96:35–41. doi: 10.1016/j.homp.2006.11.004. [DOI] [PubMed] [Google Scholar]
  • 32.Frei H, Thurneysen A, von Ammon K. Methodological difficulties in homeopathic treatment of children with ADD/ADHD. J Altern Complement Med. 2006;12:104. doi: 10.1089/acm.2006.12.104. author reply 104. [DOI] [PubMed] [Google Scholar]
  • 33.Quitkin FM, McGrath PJ, Rabkin JG, Stewart JW, Harrison W, Ross DC, Tricamo E, Fleiss J, Markowitz J, Klein DF. Different types of placebo response in patients receiving antidepressants.[see comment] American Journal of Psychiatry. 1991;148:197–203. doi: 10.1176/ajp.148.2.197. [DOI] [PubMed] [Google Scholar]
  • 34.Bensoussan A, Talley NJ, Hing M, Menzies R, Guo A, Ngu M. Treatment of irritable bowel syndrome with Chinese herbal medicine: a randomized controlled trial.[comment] JAMA. 1998;280:1585–1589. doi: 10.1001/jama.280.18.1585. [DOI] [PubMed] [Google Scholar]
  • 35.Yakir M, Kreitler S, Brzezinski A, Vithoulkas G, Oberbaum M, Bentwich Z. Effects of homeopathic treatment in women with premenstrual syndrome: a pilot study.[see comment] British Homœopathic Journal. 2001;90:148–153. doi: 10.1054/homp.1999.0491. [DOI] [PubMed] [Google Scholar]
  • 36.Jacobs J, Jimenez LM, Gloyd SS, Gale JL, Crothers D. Treatment of acute childhood diarrhea with homeopathic medicine: a randomized clinical trial in Nicaragua. Pediatrics. 1994;93:719–725. [PubMed] [Google Scholar]
  • 37.Jacobs J, Jonas WB, Jimenez-Perez M, Crothers D. Homeopathy for childhood diarrhea: combined results and metaanalysis from three randomized, controlled clinical trials. Pediatric Infectious Disease Journal. 2003;22:229–234. doi: 10.1097/01.inf.0000055096.25724.48. [DOI] [PubMed] [Google Scholar]
  • 38.Frass M, Linkesch M, Banyai S, Resch G, Dielacher C, Lobl T, Endler C, Haidvogl M, Muchitsch I, Schuster E. Adjunctive homeopathic treatment in patients with severe sepsis: a randomized, double-blind, placebo-controlled trial in an intensive care unit. Homeopathy: the Journal of the Faculty of Homeopathy. 2005;94:75–80. doi: 10.1016/j.homp.2005.01.002. [DOI] [PubMed] [Google Scholar]
  • 39.Fisher P, Greenwood A, Huskisson EC, Turner P, Belon P. Effect of homeopathic treatment on fibrositis (primary fibromyalgia) British Medical Journal. 1989;299:365–366. doi: 10.1136/bmj.299.6695.365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Gibson RG, Gibson SL, MacNeill AD, Buchanan WW. Homœopathic therapy in rheumatoid arthritis: evaluation by double-blind clinical therapeutic trial. British Journal of Clinical Pharmacology. 1980;9:453–459. doi: 10.1111/j.1365-2125.1980.tb05840.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Weatherley-Jones E, Nicholl JP, Thomas KJ, Parry GJ, McKendrick MW, Green ST, Stanley PJ, Lynch SP. A randomised, controlled, triple-blind trial of the efficacy of homeopathic treatment for chronic fatigue syndrome.[see comment] Journal of Psychosomatic Research. 2004;56:189–197. doi: 10.1016/S0022-3999(03)00377-5. [DOI] [PubMed] [Google Scholar]
  • 42.Jacobs J, Williams AL, Girard C, V.Y. N, Katz D. Homeopathy for attention-deficit/hyperactivity disorder: a pilot randomized controlled trial. Journal of Alternative & Complementary Medicine. 2005;11:799–806. doi: 10.1089/acm.2005.11.799. [DOI] [PubMed] [Google Scholar]
  • 43.Bonne O, Shemer Y, Gorali Y, Katz M, Shalev AY. A randomized, double-blind, placebo-controlled study of classical homeopathy in generalized anxiety disorder. Journal of Clinical Psychiatry. 2003;64:282–287. doi: 10.4088/jcp.v64n0309. [DOI] [PubMed] [Google Scholar]
  • 44.Fisher P, Scott DL. A randomized controlled trial of homeopathy in rheumatoid arthritis. Rheumatology. 2001;40:1052–1055. doi: 10.1093/rheumatology/40.9.1052. [DOI] [PubMed] [Google Scholar]
  • 45.Owen D. Principles and Practice of Homeopathy: The Therapeutic and Healing Process. Churchill Livingstone; 2007. [Google Scholar]
  • 46.Rowe T. Repertory, Case Taking, and Case Analysis. Berkeley: North Atlantic Books; 1998. Homeopathic Methodology. [Google Scholar]
  • 47.Vithoulkas G. The Science of Homeopathy. N.Y.: Grove Weidenfeld; 1980. [Google Scholar]
  • 48.Bell IR. All evidence is equal, but some evidence is more equal than others: can logic prevail over emotion in the homeopathy debate? J Altern Complement Med. 2005;11:763–769. doi: 10.1089/acm.2005.11.763. [DOI] [PubMed] [Google Scholar]
  • 49.Oberbaum M, Vithoulkas G, Van Haselen R. Clinical trials of classical homeopathy: reflections on appropriate research designs. Journal of Alternative & Complementary Medicine. 2003;9:105–111. doi: 10.1089/107555303321222982. [DOI] [PubMed] [Google Scholar]
  • 50.Thompson TD, Weiss M. Homeopathy—what are the active ingredients? An exploratory study using the UK Medical Research Council’s framework for the evaluation of complex interventions. BMC Complement Altern Med. 2006;13:37. doi: 10.1186/1472-6882-6-37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Jacobs J, Herman P, Heron K, Olsen S, Vaughters L. Homeopathy for menopausal symptoms in breast cancer survivors: a preliminary randomized controlled trial. Journal of Alternative and Complementary Medicine. 2005;11:21–27. doi: 10.1089/acm.2005.11.21. [DOI] [PubMed] [Google Scholar]
  • 52.Alraek T, Baerheim A. The effect of prophylactic acupuncture treatment in women with recurrent cystitis: kidney patients fare better. J Altern Complement Med. 2003;9:651–658. doi: 10.1089/107555303322524508. [DOI] [PubMed] [Google Scholar]
  • 53.Honda K, Jacobson JS. Use of complementary and alternative medicine among United States adults: the influences of personality, coping strategies, and social support. Preventive Medicine. 2005;40:46–53. doi: 10.1016/j.ypmed.2004.05.001. [DOI] [PubMed] [Google Scholar]
  • 54.Bell IR, Lewis DA, 2nd, Brooks AJ, Schwartz GE, Lewis SE, Caspi O, Cunningham V, Baldwin CM. Individual differences in response to randomly assigned active individualized homeopathic and placebo treatment in fibromyalgia: implications of a double-blinded optional crossover design. Journal of Alternative & Complementary Medicine. 2004;10:269–283. doi: 10.1089/107555304323062266. [DOI] [PubMed] [Google Scholar]
  • 55.Pulliam C, Gatchel RJ, Robinson RC. Challenges to early prevention and intervention: personal experiences with adherence. Clinical Journal of Pain. 2003;19:114–120. doi: 10.1097/00002508-200303000-00006. [DOI] [PubMed] [Google Scholar]
  • 56.Jackevicius CA, Li P, Tu JV. Prevalence, predictors, and outcomes of primary nonadherence after acute myocardial infarction. Circulation. 2008;117:1028–1036. doi: 10.1161/CIRCULATIONAHA.107.706820. [DOI] [PubMed] [Google Scholar]
  • 57.Launsø L, Henningsen I, Rieper J, Brender H, Sandø F, Hvenegaard A. Expectations and effectiveness of medical treatment and classical homeopathic treatment for patients with hypersensitivity illnesses—one year prospective study. Homeopathy. 2007;96:233–242. doi: 10.1016/j.homp.2007.08.011. [DOI] [PubMed] [Google Scholar]
  • 58.Leuchter AF, Morgan M, Cook IA, Dunkin J, Abrams M, Witte E. Pretreatment neurophysiological and clinical characteristics of placebo responders in treatment trials for major depression. Psychopharmacology (Berl) 2004;177:15–22. doi: 10.1007/s00213-004-1919-2. [DOI] [PubMed] [Google Scholar]
  • 59.Leuchter AF, Cook IA, Witte EA, Morgan M, Abrams M. Changes in brain function of depressed subjects during treatment with placebo. American Journal of Psychiatry. 2002;159:122–129. doi: 10.1176/appi.ajp.159.1.122. [DOI] [PubMed] [Google Scholar]
  • 60.Hunter AM, Cook IA, Leuchter AF. The promise of the quantitative electroencephalogram as a predictor of antidepressant treatment outcomes in major depressive disorder. Psychiatr Clin North Am. 2007;30:105–124. doi: 10.1016/j.psc.2006.12.002. [DOI] [PubMed] [Google Scholar]
  • 61.Bell IR, Lewis DA, 2nd, Schwartz GE, Lewis SE, Caspi O, Scott A, Brooks AJ, Baldwin CM. Electroencephalographic cordance patterns distinguish exceptional clinical responders with fibromyalgia to individualized homeopathic medicines. Journal of Alternative & Complementary Medicine. 2004;10:285–299. doi: 10.1089/107555304323062275. [DOI] [PubMed] [Google Scholar]
  • 62.Oberbaum M, Singer SR, Vithoulkas G. The colour of the homeopathic improvement: the multidimensional nature of the response to homeopathic therapy. Homeopathy. 2005;94:196–199. doi: 10.1016/j.homp.2005.05.004. [DOI] [PubMed] [Google Scholar]
  • 63.Aickin M. The end of biomedical journals: there is madness in their methods. Journal of Alternative & Complementary Medicine. 2005;11:755–757. doi: 10.1089/acm.2005.11.755. [DOI] [PubMed] [Google Scholar]
  • 64.Shang A, Huwiler-Muntener K, Nartey L, Juni P, Dorig S, Sterne JA, Pewsner D, Egger M. Are the clinical effects of homoeopathy placebo effects? Comparative study of placebo-controlled trials of homoeopathy and allopathy. Lancet. 2005;366:726–732. doi: 10.1016/S0140-6736(05)67177-2. [DOI] [PubMed] [Google Scholar]
  • 65.Tabachnick BG, Fidell LS. Using Multivariate Statistics. 4th ed. Boston: Allyn and Bacon; 2001. [Google Scholar]
  • 66.Abu-Asab M, Chaouchi M, Amri H. Evolutionary medicine: a meaningful connection between omics, disease, and treatment. Proteomics Clin. Appl. 2008;2:122–134. doi: 10.1002/prca.200780047. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Yang ACC, Peng C-K, Yien HW, Goldberger AL. Information categorization approach to literary authorship disputes. Physica A. 2003;329:473–483. [Google Scholar]
  • 68.Scholten J. Homeopathy and the Elements. Utrecht, the Netherlands: Stichting Alonnissos; 1996. [Google Scholar]
  • 69.Sankaran R. Sensation Refined. Mumbai, India: Homeopathic Medical Publishers; 2007. [Google Scholar]
  • 70.Davidson J, Fisher P, van Haselen R, Woodbury M, Connor K. Do constitutional types really exist? A further study using grade of membership analysis. British Homœopathic Journal. 2001;90:138–147. doi: 10.1054/homp.1999.0483. [DOI] [PubMed] [Google Scholar]
  • 71.van Haselen RA, Cinar S, Fisher P, Davidson J. The Constitutional Type Questionnaire: validation in the patient population of the Royal London Homœopathic Hospital. British Homœopathic Journal. 2001;90:131–137. doi: 10.1054/homp.1999.0493. [DOI] [PubMed] [Google Scholar]
  • 72.Walach H. What happens in homeopathic remedy provings? Results from a double-blind crossover study of belladonna 30CH and an analysis by grade of membership (GoM) In: Chez RA, editor. Future Directions and Current Issues of Research in Homeopathy. Freiburg, Germany: Samueli Institute; 2002. pp. 110–133. [Google Scholar]
  • 73.Trochim WMK. The Research Methods Knowledge Base. 2nd ed. Cincinnati, OH: Atomic Dog Publishing; 2001. [Google Scholar]
  • 74.Baldwin CM, Kroesen K, Trochim W, Bell IR. CAM survey development for US military veterans: concept mapping with an expert panel. BMC Complementary and Alternative Medicine. 2004:4. doi: 10.1186/1472-6882-4-2. www.biomedcentral.com/bmccomplementalternmed/ [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Sankaran R. Sankaran’s Schema. Mumbai, India: Homeopathic Medical Publishers; 2005. [Google Scholar]
  • 76.Miller G, Chen E. Unfavorable socioeconomic conditions in early life presage expression of proinflammatory phenotype in adolescence. Psychosom Med. 2007;69:402–409. doi: 10.1097/PSY.0b013e318068fcf9. [DOI] [PubMed] [Google Scholar]
  • 77.Marin TJ, Chen E, Miller GE. What do trajectories of childhood socioeconomic status tell us about markers of cardiovascular health in adolescence? Psychosom Med. 2008;70:152–159. doi: 10.1097/PSY.0b013e3181647d16. [DOI] [PubMed] [Google Scholar]
  • 78.Chen E, Hanson MD, Paterson LQ, Griffin MJ, Walker HA, Miller GE. Socioeconomic status and inflammatory processes in childhood asthma: the role of psychological stress. J Allergy Clin Immunol. 2006;117:1014–1020. doi: 10.1016/j.jaci.2006.01.036. [DOI] [PubMed] [Google Scholar]
  • 79.Ehlers CL, Havstad JW, Schuckit MA. EEG dimension in sons of alcoholics. Alcohol Clinical Experimental Research. 1995;19:992–998. doi: 10.1111/j.1530-0277.1995.tb00979.x. [DOI] [PubMed] [Google Scholar]
  • 80.Weatherley-Jones E, Thompson E, Thomas K. The placebo-controlled trial as a test of complementary and alternative medicine: observations from research experience of individualised homeopathic treatment. Homeopathy. 2004;93:186–189. doi: 10.1016/j.homp.2004.06.002. [DOI] [PubMed] [Google Scholar]
  • 81.Schmiedel V, Klein P. A complex homeopathic preparation for the symptomatic treatment of upper respiratory infections associated with the common cold: An observational study. Explore (NY) 2006;2:109–114. doi: 10.1016/j.explore.2005.12.008. [DOI] [PubMed] [Google Scholar]
  • 82.Steinsbekk A, Ludtke R. Patients’ assessments of the effectiveness of homeopathic care in Norway: a prospective observational multi-centre outcome study. Homeopathy: the Journal of the Faculty of Homeopathy. 2005;94:10–16. doi: 10.1016/j.homp.2004.11.016. [DOI] [PubMed] [Google Scholar]
  • 83.Spence DS, Thompson EA, Barron SJ. Homeopathic treatment for chronic disease: a 6-year, university-hospital outpatient observational study. J Altern Complement Med. 2005;11:793–798. doi: 10.1089/acm.2005.11.793. [DOI] [PubMed] [Google Scholar]
  • 84.Derasse M, Klein P, Weiser M. The effects of a complex homeopathic medicine compared with acetaminophen in the symptomatic treatment of acute febrile infections in children: an observational study. Explore (NY) 2005;1:33–39. doi: 10.1016/j.explore.2004.10.006. [DOI] [PubMed] [Google Scholar]
  • 85.Van Wassenhoven M, Ives G. An observational study of patients receiving homeopathic treatment.[see comment] Homeopathy: the Journal of the Faculty of Homeopathy. 2004;93:3–11. doi: 10.1016/j.homp.2003.11.010. [DOI] [PubMed] [Google Scholar]
  • 86.Schlappack O. Homeopathic treatment of radiation-induced itching in breast cancer patients. A prospective observational study. Homeopathy: the Journal of the Faculty of Homeopathy. 2004;93:210–215. doi: 10.1016/j.homp.2004.06.004. [DOI] [PubMed] [Google Scholar]
  • 87.Riley D, Fischer M, Singh B, Haidvogl M, Heger M. Homeopathy and conventional medicine: an outcomes study comparing effectiveness in a primary care setting. Journal of Alternative & Complementary Medicine. 2001;7:149–159. doi: 10.1089/107555301750164226. [DOI] [PubMed] [Google Scholar]
  • 88.Witt C, Keil T, Selim D, Roll S, Vance W, Wegscheider K, Willich SN. Outcome and costs of homœopathic and conventional treatment strategies: a comparative cohort study in patients with chronic disorders. Complement Ther Med. 2005;13:79–86. doi: 10.1016/j.ctim.2005.03.005. [DOI] [PubMed] [Google Scholar]
  • 89.Witt CM, Luedtke R, Baur R, Willich SN. Homeopathic Medical Practice: Long-term results of a Cohort Study with 3981 Patients. BMC Public Health. 2005;5:115. doi: 10.1186/1471-2458-5-115. epub. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90.Bornhoft G, Wolf U, Ammon K, Righetti M, Maxion-Bergemann S, Baumgartner S, Thurneysen AE, Matthiessen PF. Effectiveness, safety and cost-effectiveness of homeopathy in general practice—summarized health technology assessment. Forsch Komplementarmed. 2006;13:19–29. doi: 10.1159/000093586. [DOI] [PubMed] [Google Scholar]
  • 91.Goldstein MS, Glik D. Use of and satisfaction with homeopathy in a patient population. Alternative Therapies in Health & Medicine. 1998;4:60–65. [PubMed] [Google Scholar]
  • 92.Guthlin C, Lange O, Walach H. Measuring the effects of acupuncture and homoeopathy in general practice: an uncontrolled prospective documentation approach. BMC Public Health. 2004;4:4. doi: 10.1186/1471-2458-4-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 93.Sevar R. Audit of outcome in 455 consecutive patients treated with homeopathic medicines. Homeopathy. 2005;94:215–221. doi: 10.1016/j.homp.2005.07.002. [DOI] [PubMed] [Google Scholar]
  • 94.Haidvogl M, Riley DS, Heger M, Brien S, Jong M, Fischer M, Lewith GT, Jansen G, Thurneysen AE. Homeopathic and conventional treatment for acute respiratory and ear complaints: a comparative study on outcome in the primary care setting. BMC Complement Altern Med. 2007;2:7. doi: 10.1186/1472-6882-7-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 95.Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. New England Journal of Medicine. 2000;342:1887–1892. doi: 10.1056/NEJM200006223422507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 96.Concato J, Horwitz RI. Beyond randomised versus observational studies. Lancet. 2004;363:1660–1661. doi: 10.1016/S0140-6736(04)16285-5. [DOI] [PubMed] [Google Scholar]
  • 97.Tolle E. A New Earth: Awakening to Your Life’s Purpose. New York, NY: Plume; 2006. [Google Scholar]
  • 98.Bikker AP, Mercer SW, Reilly D. A pilot prospective study on the consultation and relational empathy, patient enablement, and health changes over 12 months in patients going to the Glasgow Homœopathic Hospital. J Altern Complement Med. 2005;11:591–600. doi: 10.1089/acm.2005.11.591. [DOI] [PubMed] [Google Scholar]
  • 99.Van Wassenhoven M, Ives G. An observational study of patients receiving homeopathic treatment. Homeopathy. 2004;93:3–11. doi: 10.1016/j.homp.2003.11.010. [DOI] [PubMed] [Google Scholar]
  • 100.Paterson C, Thomas K, Manasse A, Cooke H, Peace G. Measure Yourself Concerns and Wellbeing (MYCaW): an individualised questionnaire for evaluating outcome in cancer support care that includes complementary therapies. Complement Ther Med. 2007;15:38–45. doi: 10.1016/j.ctim.2006.03.006. [DOI] [PubMed] [Google Scholar]
  • 101.Bell IR, Meek P, Weldon V, Caspi O, Ferro L. Validation of a global well-being rating scale for integrative medicine outcomes research. Alternative Therapies in Health and Medicine Supplement. 2001;7:S4–S5. [Google Scholar]
  • 102.Paterson C. Measuring outcome in primary care: a patient-generated measure, MYMOP, compared to the SF-36 health survey. British Medical Journal. 1996;312:1016–1020. doi: 10.1136/bmj.312.7037.1016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 103.Denzin NK, Lincoln YS. Handbook of Qualitative Research. 2nd ed. Thousand Oaks, CA: Sage; 2000. [Google Scholar]
  • 104.Bell IR, Koithan M, Gorman MM, Baldwin CM. Homeopathic practitioner views of changes in patients undergoing constitutional treatment for chronic disease. Journal of Alternative & Complementary Medicine. 2003;9:39–50. doi: 10.1089/107555303321222937. [DOI] [PubMed] [Google Scholar]
  • 105.Thompson TD. Can the caged bird sing? Reflections on the application of qualitative research methods to case study design in homeopathic medicine. BMC Medical Research Methodology. 2004;4:4. doi: 10.1186/1471-2288-4-4. www.biomedcentral.com/content/pdf/1471-2288-4-4.pdf. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 106.Verhoef MJ, Casebeer AL, Hilsden RJ. Assessing efficacy of complementary medicine: adding qualitative research methods to the “Gold Standard.”. J Alternative & Complementary Medicine. 2002;8:275–281. doi: 10.1089/10755530260127961. [DOI] [PubMed] [Google Scholar]
  • 107.Denzin NK, Lincoln YS, editors. The Sage Handbook of Qualitative Research. 3rd ed. Thousand Oaks, CA: Sage; 2005. [Google Scholar]
  • 108.Pope C, Mays N, editors. Qualitative Research in Health Care. London: BMJ Books; 2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 109.Bell IR, Koithan M. Models for the study of whole systems. Integrative Cancer Therapies. 2006;5:293–307. doi: 10.1177/1534735406295293. [DOI] [PubMed] [Google Scholar]
  • 110.Bell IR, Caspi O, Schwartz GE, Grant KL, Gaudet TW, Rychener D, Maizes V, Weil A. Integrative medicine and systemic outcomes research: issues in the emergence of a new model for primary health care. Archives of Internal Medicine. 2002;162:133–140. doi: 10.1001/archinte.162.2.133. [DOI] [PubMed] [Google Scholar]
  • 111.Torres JL. Homeopathic effect: a network perspective. Homeopathy: the Journal of the Faculty of Homeopathy. 2002;91:89–94. doi: 10.1054/homp.2002.0007. [DOI] [PubMed] [Google Scholar]
  • 112.Bellavite P, Signorini A. Complexity, Biodynamics, and Nanopharmacology. Berkeley: North Atlantic Books; 2002. The Emerging Science of Homeopathy; p. 408. [Google Scholar]
  • 113.Bellavite P. Complexity science and homeopathy: a synthetic overview. Homeopathy: the Journal of the Faculty of Homeopathy. 2003;92:203–212. doi: 10.1016/j.homp.2003.08.002. [DOI] [PubMed] [Google Scholar]
  • 114.Shepperd J. Chaos theory: implications for homeopathy. Journal of the American Institute of Homeopathy. 1994;87:22. [Google Scholar]
  • 115.Hyland ME, Lewith GT. Oscillatory effects in a homeopathic clinical trial: an explanation using complexity theory, and implications for clinical practice. Homeopathy. 2002;91:145–149. doi: 10.1054/homp.2002.0025. [DOI] [PubMed] [Google Scholar]
  • 116.Bell IR, Baldwin CM, Schwartz GE. Translating a nonlinear systems theory model for homeopathy into empirical tests. Alternative Therapies in Health & Medicine. 2002;8:58–66. [PubMed] [Google Scholar]
  • 117.Bar-Yam Y. Dynamics of Complex Systems. Reading, MA: Perseus Books; 1997. [Google Scholar]
  • 118.Bar-Yam Y. Making Things Work: Solving Complex Problems in a Complex World. Knowledge Press; 2004. [Google Scholar]
  • 119.Barabasi AL. How everything is connected to everything else and what it means for business, science, and everyday life. Cambridge, MA: Plume; 2003. Linked. [Google Scholar]
  • 120.Langton CG. An Overview. Cambridge, MA: MIT Press; 1995. Artificial Life. [Google Scholar]
  • 121.Langton CG. Life at the edge of chaos. In: Langton CG, Taylor JD, Farmer D, Rasmussen S, editors. Artificial Life II. Santa Fe Institute Studies in the Sciences of Complexity. X. Redwood City, CA: Addison-Wesley; 1991. pp. 41–91. [Google Scholar]
  • 122.Rasmussen S, Chen L, Nilsson M, Abe S. Bridging nonliving and living matter. Artificial Life. 2003;9:269–316. doi: 10.1162/106454603322392479. [DOI] [PubMed] [Google Scholar]
  • 123.Fredrickson BL, Losada MF. Positive affect and the complex dynamics of human flourishing. American Psychologist. 2005;60:678–686. doi: 10.1037/0003-066X.60.7.678. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 124.Lipsitz LA, Goldberger AL. Loss of ‘complexity’ and aging. Potential applications of fractals and chaos theory to senescence. JAMA. 1992;267:1806–1809. [PubMed] [Google Scholar]
  • 125.Goldberger AL. Non-linear dynamics for clinicians: chaos theory, fractals, and complexity at the bedside. Lancet. 1996;347:1312–1314. doi: 10.1016/s0140-6736(96)90948-4. [DOI] [PubMed] [Google Scholar]
  • 126.Goldberger AL, West BJ. Fractals in physiology and medicine. Yale Journal of Biology and Medicine. 1987;60:421–435. [PMC free article] [PubMed] [Google Scholar]
  • 127.Goldberger AL, Amaral LAN, Hausdorff JM, Ivanov PC, Peng CK, Stanley HE. Fractal dynamics in physiology: alterations with disease and aging. Proceedings of the National Academy of Sciences. 2002;99:2466–2472. doi: 10.1073/pnas.012579499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 128.Costa M, Goldberger AL, Peng CK. Multiscale entropy analysis of complex physiologic time series. Phys Rev Lett. 2002;89 doi: 10.1103/PhysRevLett.89.068102. 068102:1-4. [DOI] [PubMed] [Google Scholar]
  • 129.Coffey DS. Self-organization, complexity, and chaos: the new biology for medicine. Nature Medicine. 1998;4:882–885. doi: 10.1038/nm0898-882. [DOI] [PubMed] [Google Scholar]
  • 130.Hyland M. Extended network generalized entanglement theory: therapeutic mechanisms, empirical predictions, and investigations. Journal of Alternative & Complementary Medicine. 2003;9:919–936. doi: 10.1089/107555303771952262. [DOI] [PubMed] [Google Scholar]
  • 131.Losada M. The complex dynamics of high performance teams. Mathematical Computer Modelling. 1999;30:179–192. [Google Scholar]
  • 132.Losada M, Heaphy E. The role of positivity and connectivity in the performance of business teams: a nonlinear dynamics model. American Behavioral Scientist. 2004;47:740–765. [Google Scholar]
  • 133.Waldrop MM. The Emerging Science at the Edge of Order and Chaos. NY: Touchstone; 1992. Complexity. [Google Scholar]
  • 134.Bertani S, Lussignoli S, Andrioli G, Bellavite P, Conforti A. Dual effects of a homeopathic mineral complex on carrageenan-induced oedema in rats. British Homœopathic Journal. 1999;88:101–105. doi: 10.1054/homp.1999.0310. [DOI] [PubMed] [Google Scholar]
  • 135.Kauffman S. The Search for the Laws of Self-Organization and Complexity. NY: Oxford University Press; 1995. At Home in the Universe. [Google Scholar]
  • 136.Hollenstein T, Granic I, Stoolmiller M, Snyder J. Rigidity in Parent-Child Interactions and the Development of Externalizing and Internalizing Behavior in Early Childhood. Journal of Abnormal Child Psychology. 2004;32:595. doi: 10.1023/b:jacp.0000047209.37650.41. [DOI] [PubMed] [Google Scholar]
  • 137.Granic I, Hollenstein T, Dishion TJ, Patterson GR. Longitudinal Analysis of Flexibility and Reorganization in Early Adolescence: A Dynamic Systems Study of Family Interactions. Developmental Psychology. 2003;39:606–617. doi: 10.1037/0012-1649.39.3.606. [DOI] [PubMed] [Google Scholar]
  • 138.Granic I, Hollenstein T. Dynamic systems methods for models of developmental psychopathology. Dev Psychopathol. 2003;15:641–669. doi: 10.1017/s0954579403000324. [DOI] [PubMed] [Google Scholar]
  • 139.Granic IA, Hollenstein T. A survey of dynamic systems methods for developmental psychopathology. In: Cicchetti D, Cohen DJ, editors. Developmental Psychopathology. John Wiley and Sons; 2006. pp. 889–930. [Google Scholar]
  • 140.Hollenstein T. State space grids: analyzing dynamics across development. International Journal of Behavioral Development. 2007;31:384–396. [Google Scholar]
  • 141.Lewis MD, Zimmerman S, Hollenstein T, Lamey AV. Reorganization of coping behavior at 1½ years: dynamic systems and normative change. Developmental Science. 2004;7:56–73. doi: 10.1111/j.1467-7687.2004.00323.x. [DOI] [PubMed] [Google Scholar]
  • 142.Mandell AJ, Selz KA. Nonlinear dynamical patterns as personality theory for neurobiology and psychiatry. Psychiatry. 1995;58:371–390. doi: 10.1080/00332747.1995.11024741. [DOI] [PubMed] [Google Scholar]
  • 143.Granic I, O’Hara A, Pepler D, Lewis MD. A Dynamic Systems Analysis of Parent-Child Changes Associated with Successful “Real-World” Interventions for Aggressive Children. Journal of Abnormal Child Psychology. 2007;35:845–857. doi: 10.1007/s10802-007-9133-4. [DOI] [PubMed] [Google Scholar]
  • 144.Sherr J. Syphilis: A Study of Syphilitic Miasm through Remedies. Great Malvern Worcestershire, England: Dynamis Books; 2002. Dynamic Materia Medica. [Google Scholar]
  • 145.Paydarfar D, DM B. Sporadic apnea: paradoxical transformation to eupnea by perturbations that inhibit inspiration. Med Hypotheses. 1997;49:19–26. doi: 10.1016/s0306-9877(97)90246-2. [DOI] [PubMed] [Google Scholar]
  • 146.Lewis MD, Granic I, Lamm C. Behavioral differences in aggressive children linked with neural mechanisms of emotion regulation. Ann N Y Acad Sci. 2006;1094:164–177. doi: 10.1196/annals.1376.017. [DOI] [PubMed] [Google Scholar]
  • 147.Granic I. Timing Is Everything: Developmental Psychopathology from a Dynamic Systems Perspective. Developmental Review. 2005;25:386–407. [Google Scholar]
  • 148.Koithan M, Verhoef M, Bell IR, Ritenbaugh C, White M, Mulkins A. The process of whole person healing: “unstuckness” and beyond. J Altern Complement Med. 2007;13:659–668. doi: 10.1089/acm.2007.7090. [DOI] [PubMed] [Google Scholar]
  • 149.Woyshville MJ, Lackamp JM, Eisengart JA, Gilliland JA. On the meaning and measurement of affective instability: clues from chaos theory.[erratum appears in Biol Psychiatry 1999 Apr 15;45(8):following 1081] Biological Psychiatry. 1999;45:261–269. doi: 10.1016/s0006-3223(98)00152-8. [DOI] [PubMed] [Google Scholar]
  • 150.Gottschalk A, Bauer MS, Whybrow PC. Evidence of chaotic mood variation in bipolar disorder.[comment] Archives of General Psychiatry. 1995;52:947–959. doi: 10.1001/archpsyc.1995.03950230061009. [DOI] [PubMed] [Google Scholar]
  • 151.Molle M, Marshall L, Lutzenberger W, Pietrowsky R, Fehm HL, Born J. Enhanced dynamic complexity in the human EEG during creative thinking. Neurosci Lett. 1996;208:61–64. doi: 10.1016/0304-3940(96)12539-8. [DOI] [PubMed] [Google Scholar]
  • 152.Woyshville MJ, Calabrese JR. Quantification of occipital EEG changes in Alzheimer’s disease utilizing a new metric: the fractal dimension. Biological Psychiatry. 1994;35:381–387. doi: 10.1016/0006-3223(94)90004-3. [DOI] [PubMed] [Google Scholar]
  • 153.Yang ACC, Hseu SS, Yien HW, Goldberger AL, Peng CK. Linguistic analysis of the human heartbeat using frequency and rank order statistics. Phys Rev Lett. 2003;90:108103. doi: 10.1103/PhysRevLett.90.108103. [DOI] [PubMed] [Google Scholar]
  • 154.Lewith GT, Watkins AD, Hyland ME, Shaw S, Broomfield JA, Dolan G, Holgate ST. Use of ultramolecular potencies of allergen to treat asthmatic people allergic to house dust mite: double blind randomised controlled clinical trial. BMJ. 2002;324:520–523. doi: 10.1136/bmj.324.7336.520. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 155.Vasquez A, Dobrin R, Sergi D, Eckmann JP, Oltvai ZN, Barabasi AL. The topological relationship between the large-scale attributes and local interaction patterns of complex networks. Proceedings of the National Academy of Sciences of the United States of America. 2004;101:17940–17945. doi: 10.1073/pnas.0406024101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 156.Barabasi AL, Bonabeau E. Scale-free networks. Scientific American. 2003;288:60–69. doi: 10.1038/scientificamerican0503-60. [DOI] [PubMed] [Google Scholar]
  • 157.Langman MJS. Homeopathy trials: reason for good ones but are they warranted? Lancet. 1997;350:825. doi: 10.1016/s0140-6736(05)62025-9. [DOI] [PubMed] [Google Scholar]
  • 158.Lancet T. The end of homeopathy. Lancet. 2005;366:690. [Google Scholar]
  • 159.Roy R, Tiller W, Bell IR, Hoover MR. The Structure of Liquid Water: Novel Insights from Materials Research and Potential Relevance to Homeopathy. Materials Research Innovation. 2005;9:557–608. [Google Scholar]
  • 160.Rao ML, Roy R, Bell IR. The defining role of structure (including epitaxy) in the plausibility of homeopathy. Homeopathy. 2007;96:175–182. doi: 10.1016/j.homp.2007.03.009. [DOI] [PubMed] [Google Scholar]
  • 161.Chaplin M. [accessed 04/2708];Water cluster structure. www.martin.chaplin.btinternet.co.uk/abstrct.html: [Google Scholar]
  • 162.Chaplin MF. The Memory of Water: an overview. Homeopathy. 2007;96:143–150. doi: 10.1016/j.homp.2007.05.006. [DOI] [PubMed] [Google Scholar]
  • 163.Rao M, Roy R, Bell IR. Characterization of the structure of ultra dilute sols with remarkable biological properties. Materials Letters. 2008;62:1487–1490. doi: 10.1016/j.matlet.2007.09.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 164.Elia V, Niccoli M. Thermodynamics of extremely diluted aqueous solutions. Annals of the New York Academy of Sciences. 1999;879:241–248. doi: 10.1111/j.1749-6632.1999.tb10426.x. [DOI] [PubMed] [Google Scholar]
  • 165.Elia V, Niccoli M. New physico-chemical properties of extremely diluted aqueous solutions. Journal of Thermal Analysis and Calorimetry. 2004;75:815–836. [Google Scholar]
  • 166.Elia V, Napoli E, Germano R. The ‘Memory of Water’: an almost deciphered enigma. Dissipative structures in extremely dilute aqueous solutions. Homeopathy. 2007;96:163–169. doi: 10.1016/j.homp.2007.05.007. [DOI] [PubMed] [Google Scholar]
  • 167.Rey L. Thermoluminescence of ultra-high dilutions of lithium chloride and sodium chloride. Physica A: Statistical mechanics and its applications. 2003;323:67–74. [Google Scholar]
  • 168.Rey L. Can low-temperature thermoluminescence cast light on the nature of ultra-high dilutions? Homeopathy. 2007;96:170–174. doi: 10.1016/j.homp.2007.05.004. [DOI] [PubMed] [Google Scholar]
  • 169.Elia V, Napoli E, Germano R. The ‘Memory of Water’: an almost deciphered enigma. Dissipative structures in extremely dilute aqueous solutions. Homeopathy. 2007;96:163–169. doi: 10.1016/j.homp.2007.05.007. [DOI] [PubMed] [Google Scholar]
  • 170.van Wijk R, Bosman S, van Wijk EP. Thermoluminescence in ultra-high dilution research. J Altern Complement Med. 2006;12:437–443. doi: 10.1089/acm.2006.12.437. [DOI] [PubMed] [Google Scholar]
  • 171.Aabel S, Fossheim S, Rise F. Nuclear magnetic resonance (NMR) studies of homeopathic solutions. British Homœopathic Journal. 2001;90:14–20. doi: 10.1054/homp.1999.0458. [DOI] [PubMed] [Google Scholar]
  • 172.Anick DJ, Ives JA. The silica hypothesis for homeopathy: physical chemistry. Homeopathy. 2007;96:189–195. doi: 10.1016/j.homp.2007.03.005. [DOI] [PubMed] [Google Scholar]
  • 173.Elia V, Baiano S, Duro I, Napoli E, Niccoli M, Nonatelli L. Permanent physico-chemical properties of extremely diluted aqueous solutions of homeopathic medicines. Homeopathy: the Journal of the Faculty of Homeopathy. 2004;93:144–150. doi: 10.1016/j.homp.2004.04.004. [DOI] [PubMed] [Google Scholar]
  • 174.Watterson JG. Water clusters: pixels of life. In: Hameroff SR, Kaszniak AW, Scott AC, editors. Toward a Science of Consciousness. The First Tucson Discussions and Debates. Cambridge, MA: MIT Press; 1996. pp. 397–405. [Google Scholar]
  • 175.Watterson JG. The interaction of water and proteins in cellular function. Prog Molec Subcell Biol. 1991;12:113–134. [Google Scholar]
  • 176.Watterson JG. The pressure pixel—unit of life? Biosystems. 1997;41:141–152. doi: 10.1016/s0303-2647(96)01669-3. [DOI] [PubMed] [Google Scholar]
  • 177.Watterson JG. Water clusters: pixels of life. In: Hameroff SR, Kaszniak AW, Scott AC, editors. Toward a Science of Consciousness. The First Tucson Discussions and Debates. Cambridge, MA: MIT Press; 1995. pp. 397–405. [Google Scholar]
  • 178.Calabrese EJ. Toxicological awakenings: the rebirth of hormesis as a central pillar of toxicology. [Review] [62 refs] Toxicology & Applied Pharmacology. 2005;204:1–8. doi: 10.1016/j.taap.2004.11.015. [DOI] [PubMed] [Google Scholar]
  • 179.Mastrangelo D. Hormesis, epitaxy, the structure of liquid water, and the science of homeopathy. Med Sci Monit. 2006;13 SR1-8. [PubMed] [Google Scholar]
  • 180.Henschler D. The origin of hormesis: historical background and driving forces. Hum Exp Toxicol. 2006;25:347–351. doi: 10.1191/0960327106ht642oa. [DOI] [PubMed] [Google Scholar]
  • 181.Jonas WB. The future of hormesis: what is the clinical relevance to hormesis? Critical Reviews in Toxicology. 2001;31:655–658. [PubMed] [Google Scholar]
  • 182.Del Giudice E, Doglia S, Milani M, Vitiello G. Structures, correlations, and electromagnetic interactions in living matter: theory and applications. In: Frohlich H, editor. Biological Coherence and Response to External Stimuli. Berlin: Springer-Verlag; 1988. p. 49. [Google Scholar]
  • 183.Del Giudice E, Preparata G, Vitiello G. Water as a free electric dipole laser. Physics Review Letters. 1988;61:1085–1088. doi: 10.1103/PhysRevLett.61.1085. [DOI] [PubMed] [Google Scholar]
  • 184.Del Giudice E, Preparata G. Coherent dynamics as a possible explanation of biological membranes formation. Journal of Biological Physics. 1994;20:105–116. [Google Scholar]
  • 185.Del Giudice E, Preparata G. Schulte J, Endler PC. Fundamental Research in Ultra High Dilution and Homeopathy. Dordrecht, The Netherlands: Kluwer Academic Publishers; 1998. Coherent electrodynamics in water; pp. 89–103. [Google Scholar]
  • 186.Milgrom LR. Patient-practitioner-remedy (PPR) entanglement: a qualitative, non-local metaphor for homeopathy based on quantum theory. Homeopathy: the Journal of the Faculty of Homeopathy. 2002;91:239–248. doi: 10.1054/homp.2002.0055. [DOI] [PubMed] [Google Scholar]
  • 187.Milgrom LR. Towards a new model of the homeopathic process based on quantum field theory. Forsch Komplementarmed. 2006;13:174–183. doi: 10.1159/000093662. [DOI] [PubMed] [Google Scholar]
  • 188.Walach H. Entanglement model of homeopathy as an example of generalised entanglement predicted by weak quantum theory. Forschende Komplementarmedizin/Research in Complementary Medicine. 2003;10:192–200. doi: 10.1159/000073475. [DOI] [PubMed] [Google Scholar]
  • 189.Becker-Witt C, Weibhuhn TER, Ludtke R, Willich SN. Quality assessment of physical research in homeopathy. Journal of Alternative & Complementary Medicine. 2003;9:113–132. doi: 10.1089/107555303321222991. [DOI] [PubMed] [Google Scholar]
  • 190.Belon P, Carletto A, Biasi D, Caramaschi P, Poli F, Suttora F, Bambara LM. Inhibition of human basophil degranulation by successive histamine dilutions: results of a European multi-centre trial. Inflammation Research. 1999;48:S17–S18. doi: 10.1007/s000110050376. [DOI] [PubMed] [Google Scholar]
  • 191.Belon P, Cumps J, Ennis M, Mannaioni PF, Roberfroid M, Sainte-Laudy J, Wiegant FA. Histamine dilutions modulate basophil activation. Inflamm Res. 2004;53:181–188. doi: 10.1007/s00011-003-1242-0. [DOI] [PubMed] [Google Scholar]
  • 192.Doutremepuich C, Aguejouf O, Pintigny D, Sertillanges MN, De Seze O. Thrombogenic properties of ultra-low-dose of acetylsalicylic acid in a vessel model of laser-induced thrombus formation. Thrombosis Research. 1994;76:225–229. doi: 10.1016/0049-3848(94)90193-7. [DOI] [PubMed] [Google Scholar]
  • 193.van Wijk R, Wiegant FAC. The Similia Principle in Self-Recovery. Utrecht, The Netherlands: Universiteit Utrecht; 1994. Cultured Mammalian Cells in Homeopathy Research. [Google Scholar]
  • 194.Witt CM, Bluth M, Albrecht H, Weisshuhn TE, Baumgartner S, Willich SN. The in vitro evidence for an effect of high homeopathic potencies—a systematic review of the literature. Complement Ther Med. 2007;15:128–138. doi: 10.1016/j.ctim.2007.01.011. [DOI] [PubMed] [Google Scholar]
  • 195.Datta S, Mallick P, Bukhsh AR. Efficacy of a potentized homœopathic drug (Arsenicum Album-30) in reducing genotoxic effects produced by arsenic trioxide in mice: II. Comparative efficacy of an antibiotic, actinomycin D alone and in combination with either of two microdoses. Complementary Therapies in Medicine. 1999;7:156–163. doi: 10.1016/s0965-2299(99)80123-x. [DOI] [PubMed] [Google Scholar]
  • 196.Mitra K, Kundu SN, Khuda Bukhsh AR. Efficacy of a potentized homœopathic drug (Arsenicum Album-30) in reducing toxic effects produced by arsenic trioxide in mice: II. On alterations in body weight, tissue weight and total protein. Complementary Therapies in Medicine. 1999;7:24–34. doi: 10.1016/s0965-2299(99)80055-7. [DOI] [PubMed] [Google Scholar]
  • 197.Kundu SN, Mitra K, Khuda Bukhsh AR. Efficacy of a potentized homeopathic drug (Arsenicum-Aalbum-30) in reducing cytotoxic effects produced by arsenic trioxide in mice: IV. Pathological changes, protein profiles, and content of DNA and RNA. Complementary Therapies in Medicine. 2000;8:157–165. doi: 10.1054/ctim.2000.0390. [DOI] [PubMed] [Google Scholar]
  • 198.Mallick P, Chakrabarti MJ, Guha B, Khuda-Bukhsh AR. Ameliorating effect of microdoses of a potentized homeopathic drug, Arsenicum Album, on arsenic-induced toxicity in mice. BMC Complementary and Alternative Medicine. 2003;3 doi: 10.1186/1472-6882-3-7. www.biomedcentral.com/1472-6882/3/7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 199.Endler PC, Heckmann C, Lauppert E, Pongratz W, Alex J, Dieterle D, Lukitsch C, Vinattieri C, Smith CW, Senekowitsch F, Moeller H, Schulte J. The metamorphosis of amphibians and information of thyroxin storage via the bipolar fluid water and on a technical data carrier: transference via an electronic amplifier. In: Schulte JaE PC., editor. Fundamental Research in Ultra High Dilution and Homeopathy. Dordrecht, The Netherlands: Kluwer Academic Publishers; 1998. pp. 155–187. [Google Scholar]
  • 200.Sukul NC, Bala SK, Bhattacharyya B. Prolonged cataleptogenic effects of potentized homœopathic drugs. Psychopharmacology. 1986;89:338–339. doi: 10.1007/BF00174371. [DOI] [PubMed] [Google Scholar]
  • 201.Jonas W, Lin Y, Tortella F. Neuroprotection from glutamate toxicity with ultra-low dose glutamate. Neuroreport. 2001;12:335–339. doi: 10.1097/00001756-200102120-00031. [DOI] [PubMed] [Google Scholar]
  • 202.Jonas W, Lin Y, Williams A, Tortella F, Tuma R. Treatment of experimental stroke with low-dose glutamate and homeopathic Arnica montana. Perfusion. 1999;12:452–462. [Google Scholar]
  • 203.Marotta D, Marini A, Banaudha K, Maharaj S, Ives J, Morrissette CR, Jonas WB. Non-linear effects of cycloheximide in glutamate-treated cultured rat cerebellar neurons. Neurotoxicology. 2002;23:307–312. doi: 10.1016/s0161-813x(02)00058-x. [DOI] [PubMed] [Google Scholar]
  • 204.Marotta D, Marini A, Banaudha K, Maharaj S, Jonas WB. Nonlinear effects of glutamate and KCl on glutamate toxicity in cultured rat cerebellar neurons. International Journal of Neuroscience. 2003;113:45–56. doi: 10.1080/00207450390162245. [DOI] [PubMed] [Google Scholar]
  • 205.Jonas WB. Do homeopathic nosodes protect against infection? An experimental test. Alternative Therapies in Health & Medicine. 1999;5:36–40. [PubMed] [Google Scholar]
  • 206.Weber S, Endler PC, Welles SU, Suanjak-Traidl E, Scherer-Pongratz W, Frass M, Spranger H, Peithner G, Lothaller H. The effect of homeopathically prepared thyroxine on highland frogs: influence of electromagnetic fields. Homeopathy. 2008;97:3–9. doi: 10.1016/j.homp.2007.11.002. [DOI] [PubMed] [Google Scholar]
  • 207.Barber B. Resistance by scientists to scientific discovery. Science. 1961;134:596–602. doi: 10.1126/science.134.3479.596. [DOI] [PubMed] [Google Scholar]
  • 208.Caulfield T, DeBow S. A systematic review of how homeopathy is represented in conventional and CAM peer reviewed journals. BMC Complement Altern Med. 2005;5:12. doi: 10.1186/1472-6882-5-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 209.Platt JR. Strong inference. Science. 1964;146:347–353. doi: 10.1126/science.146.3642.347. [DOI] [PubMed] [Google Scholar]

RESOURCES